Submitted URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW...
Effective URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1R...
Submission: On September 21 via api from US — Scanned from DE

Summary

This website contacted 79 IPs in 10 countries across 66 domains to perform 166 HTTP transactions. The main IP is 104.18.15.141, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercepharma.com.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on July 14th 2021. Valid for: a year.
This is the only time www.fiercepharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
1 104.21.75.33 13335 (CLOUDFLAR...)
1 14 104.18.15.141 13335 (CLOUDFLAR...)
1 142.250.186.170 15169 (GOOGLE)
1 13.224.193.97 16509 (AMAZON-02)
2 104.16.92.165 13335 (CLOUDFLAR...)
4 213.174.135.2 39572 (ADVANCEDH...)
5 142.250.185.226 15169 (GOOGLE)
1 172.217.16.136 15169 (GOOGLE)
2 172.67.39.148 13335 (CLOUDFLAR...)
1 142.250.184.202 15169 (GOOGLE)
4 104.16.92.80 13335 (CLOUDFLAR...)
4 142.250.74.195 15169 (GOOGLE)
1 3.234.170.180 14618 (AMAZON-AES)
4 6 66.155.71.149 13768 (COGECO-PEER1)
1 13.224.194.156 16509 (AMAZON-02)
1 213.174.135.1 39572 (ADVANCEDH...)
1 35.163.47.212 16509 (AMAZON-02)
1 172.67.200.52 13335 (CLOUDFLAR...)
4 23.227.137.155 55081 (24SHELLS)
1 13.225.85.39 16509 (AMAZON-02)
5 142.250.185.142 15169 (GOOGLE)
4 104.19.148.8 13335 (CLOUDFLAR...)
1 23.66.157.159 16625 (AKAMAI-AS)
1 13.224.193.55 16509 (AMAZON-02)
1 104.16.168.82 13335 (CLOUDFLAR...)
2 204.180.130.159 53866 (QTS-AS)
2 52.208.138.90 16509 (AMAZON-02)
1 104.18.10.207 13335 (CLOUDFLAR...)
1 52.205.167.202 14618 (AMAZON-AES)
2 3 54.171.219.200 16509 (AMAZON-02)
1 2 35.227.248.159 15169 (GOOGLE)
1 34.254.143.3 16509 (AMAZON-02)
1 2 34.253.109.165 16509 (AMAZON-02)
2 5 185.33.220.240 29990 (ASN-APPNEX)
3 3.224.43.92 14618 (AMAZON-AES)
1 3.226.134.17 14618 (AMAZON-AES)
2 142.251.5.156 15169 (GOOGLE)
4 178.250.2.146 44788 (ASN-CRITE...)
1 37.252.161.190 29990 (ASN-APPNEX)
1 135.125.163.79 16276 (OVH)
1 213.19.147.43 26120 (RHYTHMONE)
1 178.162.133.150 60781 (LEASEWEB-...)
1 51.89.9.251 16276 (OVH)
1 34.107.148.139 15169 (GOOGLE)
1 185.239.173.66 55081 (24SHELLS)
1 96.46.186.57 7979 (SERVERS-COM)
1 147.75.38.124 54825 (PACKET)
1 216.52.2.19 30282 (AS-INAPCD...)
1 2 35.244.159.8 15169 (GOOGLE)
1 54.228.75.94 16509 (AMAZON-02)
1 88.214.207.207 46636 (NATCOWEB)
2 185.64.189.112 62713 (AS-PUBMATIC)
11 52.28.203.152 16509 (AMAZON-02)
4 213.19.162.61 26667 (RUBICONPR...)
1 178.250.2.131 44788 (ASN-CRITE...)
1 185.184.10.30 203690 (RTB-HOUSE...)
1 46.249.52.248 50673 (SERVERIUS-AS)
3 142.250.186.66 15169 (GOOGLE)
3 104.26.7.35 13335 (CLOUDFLAR...)
1 54.73.172.176 16509 (AMAZON-02)
1 172.217.23.98 15169 (GOOGLE)
1 1 162.55.6.211 24940 (HETZNER-AS)
1 2 62.149.0.72 15497 (COLOCALL ...)
1 193.200.65.5 6681 (GIVEME-CLOUD)
1 37.18.16.23 205675 (HYBRID-AS)
5 142.250.186.98 15169 (GOOGLE)
2 142.250.181.225 15169 (GOOGLE)
1 34.223.151.79 16509 (AMAZON-02)
1 52.25.225.148 16509 (AMAZON-02)
1 1 185.33.221.89 29990 (ASN-APPNEX)
1 9 52.35.10.191 16509 (AMAZON-02)
2 2 13.248.242.197 16509 (AMAZON-02)
2 2 185.64.189.110 62713 (AS-PUBMATIC)
2 3 142.250.186.34 15169 (GOOGLE)
1 151.101.193.44 54113 (FASTLY)
1 1 178.162.133.149 60781 (LEASEWEB-...)
1 35.244.174.68 15169 (GOOGLE)
2 142.250.185.100 15169 (GOOGLE)
1 142.250.185.194 15169 (GOOGLE)
1 35.82.147.164 16509 (AMAZON-02)
1 142.250.186.99 15169 (GOOGLE)
2 178.250.2.130 44788 (ASN-CRITE...)
1 51.195.5.38 ()
166 79
Apex Domain
Subdomains
Transfer
14 fiercepharma.com
www.fiercepharma.com
c405.fiercepharma.com Failed
136 KB
12 ad.gt
a.ad.gt
p.ad.gt
ids.ad.gt
pixels.ad.gt
17 KB
11 yahoo.com
c2shb.ssp.yahoo.com
5 KB
10 doubleclick.net
securepubads.g.doubleclick.net
stats.g.doubleclick.net
cm.g.doubleclick.net
164 KB
7 googlesyndication.com
4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com Failed
pagead2.googlesyndication.com
tpc.googlesyndication.com
34 KB
7 adnxs.com
ib.adnxs.com
prebid.adnxs.com
secure.adnxs.com
7 KB
7 mediafuse.com
player.mediafuse.com
hb.mediafuse.com
157 KB
5 criteo.com
gum.criteo.com
bidder.criteo.com
6 KB
5 crazyegg.com
script.crazyegg.com
tracking.crazyegg.com
26 KB
5 google-analytics.com
www.google-analytics.com
22 KB
4 google.com
adservice.google.com
www.google.com
2 KB
4 rubiconproject.com
fastlane.rubiconproject.com
6 KB
4 pubmatic.com
hbopenbid.pubmatic.com
image2.pubmatic.com
805 B
4 adtelligent.com
player.adtelligent.com
ghb.adtelligent.com
sync.adtelligent.com
6 KB
4 dpmsrv.com
s.dpmsrv.com
a.dpmsrv.com
42 KB
4 sitescout.com
pixel.sitescout.com
3 KB
4 gstatic.com
fonts.gstatic.com
82 KB
4 marketo.com
app-sj10.marketo.com
74 KB
3 b2c.com
api-34-211-87-144.b2c.com
6 KB
3 google.de
adservice.google.de
www.google.de
1 KB
3 demdex.net
dpm.demdex.net
3 KB
3 ml314.com
ml314.com
in.ml314.com
14 KB
2 criteo.net
static.criteo.net
54 KB
2 adsrvr.org
match.adsrvr.org
962 B
2 openx.net
adtelligent-d.openx.net
u.openx.net
936 B
2 sonobi.com
apex.go.sonobi.com
sync.go.sonobi.com
4 KB
2 crwdcntrl.net
bcp.crwdcntrl.net
1 KB
2 tapad.com
pixel.tapad.com
895 B
2 omeda.com
olytics.omeda.com
77 KB
2 parsely.com
cdn.parsely.com
p1.parsely.com
18 KB
2 basis.net
pixel-a.basis.net
132 B
2 addtoany.com
static.addtoany.com
62 KB
2 qtxasset.com
qtxasset.com
32 KB
2 blueconic.net
cdn.blueconic.net
questex.blueconic.net
42 KB
2 googleapis.com
fonts.googleapis.com
ajax.googleapis.com
7 KB
1 id5-sync.com
id5-sync.com
538 B
1 rlcdn.com
idsync.rlcdn.com
66 B
1 taboola.com
trc.taboola.com
238 B
1 aufp.io
aufp.io
3 KB
1 hybrid.ai
dm.hybrid.ai
238 B
1 trafmag.com
t.trafmag.com
232 B
1 loopme.me
csync.loopme.me
207 B
1 googletagservices.com
www.googletagservices.com
28 KB
1 e-planning.net
ads.us.e-planning.net
162 B
1 creativecdn.com
prebid-us.creativecdn.com
182 B
1 colossusssp.com
colossusssp.com
247 B
1 servenobid.com
ads.servenobid.com
568 B
1 lijit.com
ap.lijit.com
638 B
1 a-mo.net
prebid.a-mo.net
174 B
1 betweendigital.com
ads.betweendigital.com
916 B
1 media.net
prebid.media.net
434 B
1 onetag-sys.com
onetag-sys.com
376 B
1 1rx.io
tag.1rx.io
176 B
1 adxpremium.services
rtb.adxpremium.services
628 B
1 exelator.com
loadm.exelator.com
324 B
1 bootstrapcdn.com
maxcdn.bootstrapcdn.com
5 KB
1 zoominfo.com
ws.zoominfo.com
1 KB
1 marketo.net
munchkin.marketo.net
1 KB
1 fouanalytics.com
api.fouanalytics.com
977 B
1 medidexs.com
sync.medidexs.com
18 KB
1 cloudfront.net
d1z2jf7jlzjs58.cloudfront.net
1 KB
1 googletagmanager.com
www.googletagmanager.com
53 KB
1 questexnetwork.com
go.questexnetwork.com
1 KB
0 spotible.com Failed
ads.spotible.com Failed
0 admixer.net Failed
inv-nets.admixer.net Failed
0 teads.tv Failed
sync.teads.tv Failed
166 66
Domain Requested by
14 www.fiercepharma.com 1 redirects go.questexnetwork.com
www.fiercepharma.com
11 c2shb.ssp.yahoo.com player.mediafuse.com
9 ids.ad.gt 1 redirects www.fiercepharma.com
5 pagead2.googlesyndication.com securepubads.g.doubleclick.net
tpc.googlesyndication.com
www.fiercepharma.com
5 ib.adnxs.com 2 redirects player.mediafuse.com
www.fiercepharma.com
5 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
5 securepubads.g.doubleclick.net www.fiercepharma.com
securepubads.g.doubleclick.net
4 fastlane.rubiconproject.com player.mediafuse.com
4 gum.criteo.com player.mediafuse.com
static.criteo.net
gum.criteo.com
4 script.crazyegg.com www.googletagmanager.com
script.crazyegg.com
4 hb.mediafuse.com player.mediafuse.com
4 pixel.sitescout.com 2 redirects www.fiercepharma.com
4 fonts.gstatic.com fonts.googleapis.com
4 app-sj10.marketo.com www.fiercepharma.com
app-sj10.marketo.com
3 cm.g.doubleclick.net 2 redirects www.fiercepharma.com
3 api-34-211-87-144.b2c.com go.questexnetwork.com
www.fiercepharma.com
api-34-211-87-144.b2c.com
3 a.dpmsrv.com www.fiercepharma.com
s.dpmsrv.com
3 dpm.demdex.net 2 redirects www.fiercepharma.com
3 player.mediafuse.com www.fiercepharma.com
player.mediafuse.com
2 static.criteo.net player.mediafuse.com
static.criteo.net
2 www.google.com tpc.googlesyndication.com
www.fiercepharma.com
2 image2.pubmatic.com 2 redirects
2 match.adsrvr.org 2 redirects
2 tpc.googlesyndication.com securepubads.g.doubleclick.net
tpc.googlesyndication.com
2 sync.adtelligent.com 1 redirects player.mediafuse.com
2 adservice.google.com securepubads.g.doubleclick.net
2 adservice.google.de securepubads.g.doubleclick.net
2 hbopenbid.pubmatic.com player.mediafuse.com
2 stats.g.doubleclick.net www.google-analytics.com
2 bcp.crwdcntrl.net 1 redirects www.fiercepharma.com
2 pixel.tapad.com 1 redirects www.fiercepharma.com
2 ml314.com go.questexnetwork.com
ml314.com
2 olytics.omeda.com go.questexnetwork.com
www.googletagmanager.com
2 pixel-a.basis.net 2 redirects
2 static.addtoany.com www.fiercepharma.com
static.addtoany.com
2 qtxasset.com www.fiercepharma.com
1 id5-sync.com player.mediafuse.com
1 www.google.de www.fiercepharma.com
1 u.openx.net 1 redirects
1 pixels.ad.gt p.ad.gt
1 idsync.rlcdn.com www.fiercepharma.com
1 sync.go.sonobi.com 1 redirects
1 trc.taboola.com www.fiercepharma.com
1 secure.adnxs.com 1 redirects
1 p.ad.gt a.ad.gt
1 aufp.io a.ad.gt
1 dm.hybrid.ai www.fiercepharma.com
1 t.trafmag.com www.fiercepharma.com
1 csync.loopme.me 1 redirects
1 www.googletagservices.com securepubads.g.doubleclick.net
1 tracking.crazyegg.com script.crazyegg.com
1 ads.us.e-planning.net player.mediafuse.com
1 prebid-us.creativecdn.com player.mediafuse.com
1 bidder.criteo.com player.mediafuse.com
1 colossusssp.com player.mediafuse.com
1 ads.servenobid.com player.mediafuse.com
1 adtelligent-d.openx.net player.mediafuse.com
1 ap.lijit.com player.mediafuse.com
1 prebid.a-mo.net player.mediafuse.com
1 ads.betweendigital.com player.mediafuse.com
1 ghb.adtelligent.com player.mediafuse.com
1 prebid.media.net player.mediafuse.com
1 onetag-sys.com player.mediafuse.com
1 apex.go.sonobi.com player.mediafuse.com
1 tag.1rx.io player.mediafuse.com
1 rtb.adxpremium.services player.mediafuse.com
1 prebid.adnxs.com player.mediafuse.com
1 in.ml314.com ml314.com
1 player.adtelligent.com player.mediafuse.com
1 loadm.exelator.com www.fiercepharma.com
1 p1.parsely.com www.fiercepharma.com
1 maxcdn.bootstrapcdn.com client
1 ws.zoominfo.com go.questexnetwork.com
1 s.dpmsrv.com go.questexnetwork.com
1 munchkin.marketo.net go.questexnetwork.com
1 cdn.parsely.com d1z2jf7jlzjs58.cloudfront.net
1 api.fouanalytics.com player.mediafuse.com
1 a.ad.gt player.mediafuse.com
1 sync.medidexs.com player.mediafuse.com
1 d1z2jf7jlzjs58.cloudfront.net www.fiercepharma.com
1 questex.blueconic.net cdn.blueconic.net
1 ajax.googleapis.com www.fiercepharma.com
1 www.googletagmanager.com www.fiercepharma.com
1 cdn.blueconic.net www.fiercepharma.com
1 fonts.googleapis.com www.fiercepharma.com
1 go.questexnetwork.com
0 ads.spotible.com Failed go.questexnetwork.com
0 4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com Failed securepubads.g.doubleclick.net
0 inv-nets.admixer.net Failed player.mediafuse.com
0 c405.fiercepharma.com Failed cdn.blueconic.net
0 sync.teads.tv Failed www.fiercepharma.com
166 91

This site contains no links.

Subject Issuer Validity Valid
go.questexnetwork.com
Cloudflare Inc ECC CA-3
2021-06-03 -
2022-06-02
a year crt.sh
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2021-07-14 -
2022-07-13
a year crt.sh
upload.video.google.com
GTS CA 1O1
2021-08-30 -
2021-11-22
3 months crt.sh
*.blueconic.net
Thawte TLS RSA CA G1
2019-12-04 -
2022-02-01
2 years crt.sh
player.mediafuse.com
R3
2021-09-19 -
2021-12-18
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
app-sj10.marketo.com
Cloudflare Inc ECC CA-3
2021-06-08 -
2022-06-07
a year crt.sh
*.gstatic.com
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
*.sitescout.com
RapidSSL RSA CA 2018
2020-01-15 -
2022-02-02
2 years crt.sh
*.cloudfront.net
Amazon
2021-03-19 -
2022-03-17
a year crt.sh
sync.medidexs.com
R3
2021-09-11 -
2021-12-10
3 months crt.sh
*.ad.gt
Amazon
2021-06-09 -
2022-07-08
a year crt.sh
hb.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2021-08-10 -
2021-11-08
3 months crt.sh
*.parsely.com
Amazon
2021-07-05 -
2022-08-03
a year crt.sh
*.marketo.net
DigiCert SHA2 Secure Server CA
2021-03-29 -
2022-04-06
a year crt.sh
*.dpmsrv.com
Amazon
2021-05-17 -
2022-06-15
a year crt.sh
zoominfo.com
Cloudflare Inc ECC CA-3
2021-06-04 -
2022-06-03
a year crt.sh
*.omeda.com
SSL.com RSA SSL subCA
2021-07-16 -
2022-07-21
a year crt.sh
*.ml314.com
Amazon
2021-01-17 -
2022-02-14
a year crt.sh
*.demdex.net
DigiCert TLS RSA SHA256 2020 CA1
2020-12-02 -
2022-01-02
a year crt.sh
*.tapad.com
DigiCert SHA2 Secure Server CA
2020-10-05 -
2021-11-06
a year crt.sh
*.exelator.com
DigiCert TLS RSA SHA256 2020 CA1
2021-06-02 -
2022-06-07
a year crt.sh
*.crwdcntrl.net
Go Daddy Secure Certificate Authority - G2
2021-04-29 -
2022-05-31
a year crt.sh
*.adtelligent.com
Sectigo RSA Domain Validation Secure Server CA
2020-10-28 -
2021-11-27
a year crt.sh
*.criteo.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2021-09-09 -
2021-12-07
3 months crt.sh
prebid.adnxs.com
GeoTrust TLS RSA CA G1
2020-03-29 -
2022-03-29
2 years crt.sh
*.adxpremium.services
Sectigo RSA Domain Validation Secure Server CA
2021-08-05 -
2022-09-05
a year crt.sh
*.1rx.io
Sectigo RSA Domain Validation Secure Server CA
2021-06-01 -
2022-07-02
a year crt.sh
*.go.sonobi.com
Go Daddy Secure Certificate Authority - G2
2020-12-06 -
2022-01-07
a year crt.sh
onetag-sys.com
R3
2021-07-26 -
2021-10-24
3 months crt.sh
*.media.net
Sectigo RSA Domain Validation Secure Server CA
2021-04-12 -
2022-05-05
a year crt.sh
ghb.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2021-08-10 -
2021-11-08
3 months crt.sh
ads.betweendigital.com
Sectigo RSA Domain Validation Secure Server CA
2020-11-19 -
2021-12-20
a year crt.sh
*.a-mo.net
R3
2021-07-16 -
2021-10-14
3 months crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2021-03-05 -
2022-02-19
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2021-03-11 -
2022-04-12
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2021-07-08 -
2022-08-08
a year crt.sh
ads.servenobid.com
Amazon
2021-06-28 -
2022-07-27
a year crt.sh
*.colossusssp.com
Go Daddy Secure Certificate Authority - G2
2020-10-06 -
2021-11-07
a year crt.sh
*.pubmatic.com
DigiCert Baltimore TLS RSA SHA256 2020 CA1
2020-12-07 -
2021-12-14
a year crt.sh
web.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2021-08-30 -
2022-02-23
6 months crt.sh
*.rubiconproject.com
DigiCert TLS RSA SHA256 2020 CA1
2021-03-30 -
2022-04-04
a year crt.sh
*.creativecdn.com
RapidSSL TLS DV RSA Mixed SHA256 2020 CA-1
2021-03-30 -
2022-04-12
a year crt.sh
ads.us.e-planning.net
R3
2021-08-01 -
2021-10-30
3 months crt.sh
*.google.de
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
*.google.com
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
*.crazyegg.com
DigiCert SHA2 Secure Server CA
2020-07-26 -
2022-07-23
2 years crt.sh
sync.adtelligent.com
R3
2021-08-04 -
2021-11-02
3 months crt.sh
*.trafmag.com
Sectigo RSA Domain Validation Secure Server CA
2021-06-10 -
2022-06-22
a year crt.sh
*.hybrid.ai
Sectigo RSA Domain Validation Secure Server CA
2020-07-07 -
2022-10-05
2 years crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
aufp.io
Amazon
2020-12-26 -
2022-01-24
a year crt.sh
*.taboola.com
DigiCert TLS RSA SHA256 2020 CA1
2020-11-25 -
2021-12-26
a year crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA
2021-02-25 -
2022-03-28
a year crt.sh
www.google.com
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
www.google.de
GTS CA 1C3
2021-08-30 -
2021-11-22
3 months crt.sh
*.criteo.net
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2021-09-09 -
2021-12-07
3 months crt.sh
*.id5-sync.com
R3
2021-07-13 -
2021-10-11
3 months crt.sh

This page contains 8 frames:

Primary Page: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Frame ID: C3D4E473EEB3EB6499557B535044F7C5
Requests: 152 HTTP requests in this frame

Frame: https://pixel.sitescout.com/dmp/asyncPixelSync?cookieQ=1
Frame ID: 923254F7EB01D8DDAFEBAA12D831F876
Requests: 6 HTTP requests in this frame

Frame: https://app-sj10.marketo.com/index.php/form/XDFrame
Frame ID: D4DB71D88A185AA51C7687DF5A0D783E
Requests: 1 HTTP requests in this frame

Frame: https://4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: 858FA4246DDAD054DD39A0B0DBBF14C1
Requests: 1 HTTP requests in this frame

Frame: https://sync.adtelligent.com/csync?t=a&ep=319130&extuid=bb66e291-b090-42ef-9d5e-99e0a0cdd854
Frame ID: 32279C2DC2BFB9E3CC02E1322940C089
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/224/runner.html
Frame ID: A3D674757441DBFB2F6F397C6DE311C7
Requests: 2 HTTP requests in this frame

Frame: https://www.google.com/recaptcha/api2/aframe
Frame ID: 9A1C0EB42CC2C1928DE91D02F16125E0
Requests: 2 HTTP requests in this frame

Frame: https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fiercepharma.com
Frame ID: 09EA4E572B67133F1FC31717DBBE14E1
Requests: 2 HTTP requests in this frame

Screenshot


Page URL History Show full URLs

  1. https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5... Page URL
  2. https://www.fiercepharma.com///pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-pat... HTTP 302
    https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patie... Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
  • addtoany\.com/menu/page\.js

Overall confidence: 100%
Detected patterns
  • <(?:iframe|img)[^>]+adnxs\.(?:net|com)
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • script\.crazyegg\.com/pages/scripts/\d+/\d+\.js

Overall confidence: 100%
Detected patterns
  • (?:F|f)o(?:n|r)t-?(?:A|a)wesome(?:.*?([0-9a-fA-F]{7,40}|[\d]+(?:.[\d]+(?:.[\d]+)?)?)|)

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googleapis\.com/.+webfont

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js

Overall confidence: 100%
Detected patterns
  • munchkin\.marketo\.\w+/(?:([\d.]+)/)?munchkin\.js

Overall confidence: 100%
Detected patterns
  • marketo\.\w+/js/forms(?:[\d.]+)/js/forms([\d.]+)\.min\.js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • adnxs\.com/[^"]*(?:prebid|/pb\.js)

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.pubmatic\.com

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.rubiconproject\.com

Page Statistics

166
Requests

95 %
HTTPS

0 %
IPv6

66
Domains

91
Subdomains

79
IPs

10
Countries

1219 kB
Transfer

3704 kB
Size

101
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk= Page URL
  2. https://www.fiercepharma.com///pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?utm_medium=nl&utm_source=internal&mrkid=170732038&mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI HTTP 302
    https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038 Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 27
  • https://pixel-a.basis.net/dmp/asyncPixelSync HTTP 301
  • https://pixel.sitescout.com/dmp/asyncPixelSync HTTP 302
  • https://pixel.sitescout.com/dmp/asyncPixelSync?cookieQ=1
Request Chain 28
  • https://pixel-a.basis.net/iap/7f1874304d399254 HTTP 301
  • https://pixel.sitescout.com/iap/7f1874304d399254 HTTP 302
  • https://pixel.sitescout.com/iap/7f1874304d399254?cookieQ=1
Request Chain 55
  • https://dpm.demdex.net/ibs:dpid=82530&dpuuid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent= HTTP 302
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=82530&dpuuid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
Request Chain 56
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=2499&partner_device_id=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553 HTTP 302
  • https://pixel.tapad.com/idsync/ex/receive/check?partner_id=2499&partner_device_id=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
Request Chain 59
  • https://bcp.crwdcntrl.net/map/c=1389/tp=STSC/tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553 HTTP 302
  • https://bcp.crwdcntrl.net/map/ct=y/c=1389/tp=STSC/tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
Request Chain 60
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D360253%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fpharma%252Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%253Fmkt_tok%253DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%2526mrkid%253D170732038&_=1632240981366 HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D360253%2526tzOffset%253D0%2526url%253Dhttps%25253A%25252F%25252Fwww.fiercepharma.com%25252Fpharma%25252Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%25253Fmkt_tok%25253DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%252526mrkid%25253D170732038%26_%3D1632240981366 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=5735997925621329899&q=xImp&v=1.x&cl=913&pixelIndex=0&r=360253&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&_=1632240981366
Request Chain 121
  • https://csync.loopme.me/?redirect=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D319130%26extuid%3D%7Bdevice_id%7D HTTP 307
  • https://sync.adtelligent.com/csync?t=a&ep=319130&extuid=bb66e291-b090-42ef-9d5e-99e0a0cdd854
Request Chain 122
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D HTTP 302
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=81a1960d96ec7b55
Request Chain 129
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&adnxs_id=$UID HTTP 302
  • https://ids.ad.gt/api/v1/match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&adnxs_id=5735997925621329899
Request Chain 130
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://ids.ad.gt/api/v1/t_match?tdid=010e5372-0935-48b5-85bd-1e6e2626ad58&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Request Chain 131
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://ids.ad.gt/api/v1/pbm_match?pbm=D669AC34-AAD1-4434-8683-EE81A74C2B93&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Request Chain 132
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://ids.ad.gt/api/v1/g_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&google_gid=CAESEGI2Rf67IBhFIcjr05CHMLg&google_cver=1&google_ula=450542624,0
Request Chain 133
  • https://ids.ad.gt/api/v1/g_hosted?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=YmYzM2MwYzEtN2UwZS00NzE4LWE2YzMtN2NkMTM0ZGJhZGI0
Request Chain 135
  • https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&uid=[UID] HTTP 302
  • https://ids.ad.gt/api/v1/son_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&uid=39227249-44c9-4e14-81e2-3aebc2a43cad
Request Chain 136
  • https://dpm.demdex.net/ibs:dpid=348447&dpuuid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fadb_match%3Fadb%3D%24%7BDD_UUID%7D%26id%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://ids.ad.gt/api/v1/adb_match?adb=19663782927819267720830632050847266550&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Request Chain 137
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5735997925621329899&pixelIndex=0&_=1632240981367 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5735997925621329899&pixelIndex=0&_=1632240981367&google_gid=CAESEN7tM4cFGRweSt1qOrmM_uI&google_cver=1
Request Chain 153
  • https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3D02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1elzfjf1hl5r1i1kkc2jl%26auid%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4 HTTP 302
  • https://ids.ad.gt/api/v1/openx?openx_id=992d35b9-704a-495f-a47e-38fa4588a3d5&id=02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1elzfjf1hl5r1i1kkc2jl&auid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4

166 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCu...
608 B
1 KB
Document
General
Full URL
https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.21.75.33 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4df74cfc86e566c05ff7f65e2ff5139aa6d03637da6d084c5d43131041e0218c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:method
GET
:authority
go.questexnetwork.com
:scheme
https
:path
/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept-language
de-DE,de;q=0.9
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
none
sec-fetch-mode
navigate
sec-fetch-user
?1
sec-fetch-dest
document
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9

Response headers

date
Tue, 21 Sep 2021 16:16:19 GMT
content-type
text/html
cache-control
private, no-cache, no-store, max-age=0
x-content-type-options
nosniff
vary
Accept-Encoding
set-cookie
BIGipServersj_mailtracking_http=!8PiIn8guBIEFCsMlU8cyx3LfarvBcWtukrW2b3Xv3uZI6kqkClzclfaH4h/MiHC9Ymc7ta2CeRIVYPI=; path=/; Httponly; Secure __cf_bm=5hJNTr7gWWxaLKgN6zCnylKmTUjmAXeiJ_Jor2vNLxw-1632240979-0-AeAZDhvCtB1i9SV5TiNLGsDtp7/SUXR6NyKYQruCrNE0kRU497rAh+kt+p56tPLLK3xvL3D8BuiHlSyP280VCSg=; path=/; expires=Tue, 21-Sep-21 16:46:19 GMT; domain=.go.questexnetwork.com; HttpOnly; Secure; SameSite=None
cf-cache-status
DYNAMIC
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
692498e92a323322-CDG
content-encoding
gzip
Primary Request more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients
www.fiercepharma.com/pharma/
Redirect Chain
  • https://www.fiercepharma.com///pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?utm_medium=nl&utm_source=internal&mrkid=170732038&mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF...
  • https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06...
68 KB
19 KB
Document
General
Full URL
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b761119f6ee51a94c54a22c19e4ccf071c507d927872afab4b5db02d916ba21b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

:method
GET
:authority
www.fiercepharma.com
:scheme
https
:path
/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept-language
de-DE,de;q=0.9
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
document
referer
https://go.questexnetwork.com/
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=

Response headers

date
Tue, 21 Sep 2021 16:16:20 GMT
content-type
text/html; charset=UTF-8
cache-control
max-age=43200, public
x-drupal-dynamic-cache
MISS
link
<https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients>; rel="canonical" <https://www.fiercepharma.com/node/506671>; rel="shortlink" <https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients>; rel="revision"
x-ua-compatible
IE=edge
content-language
en
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Tue, 21 Sep 2021 16:16:20 GMT
vary
Cookie,Accept-Encoding
x-generator
Drupal 8 (https://www.drupal.org)
x-drupal-cache
MISS
x-request-id
v-41c204ca-1af7-11ec-b92c-4f99f2f3fb33
x-ah-environment
prod
via
varnish
x-cache
MISS
cf-cache-status
MISS
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
692498ef28e021ab-DUS
content-encoding
br

Redirect headers

date
Tue, 21 Sep 2021 16:16:20 GMT
content-type
text/html; charset=UTF-8
cache-control
max-age=43200, public
x-ua-compatible
IE=edge
content-language
en
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Tue, 21 Sep 2021 16:16:20 GMT
vary
Cookie, Accept-Encoding
x-generator
Drupal 8 (https://www.drupal.org)
x-drupal-cache
MISS
location
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
x-request-id
v-419973fc-1af7-11ec-b8c8-6bdc343ffad4
x-ah-environment
prod
via
varnish
x-cache
MISS
cf-cache-status
MISS
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
692498ed7cbc21ab-DUS
css2
fonts.googleapis.com/
3 KB
949 B
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.170 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s08-in-f10.1e100.net
Software
ESF /
Resource Hash
dbeae36aa0b1cfa4f2c3e334f599ca42baabde1c4a27d7e1735a0311f77a8d9e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Tue, 21 Sep 2021 16:16:21 GMT
server
ESF
date
Tue, 21 Sep 2021 16:16:21 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Tue, 21 Sep 2021 16:16:21 GMT
css_dmGT3vzMbuQEYT4GrtSmlKGvHMg3EMN2fdyDplKSdzU.css
www.fiercepharma.com/sites/fiercepharma/files/css/
8 KB
2 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_dmGT3vzMbuQEYT4GrtSmlKGvHMg3EMN2fdyDplKSdzU.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b89736430f0c3089ec96f72dcb85cb4ba00bb868724f4d976b05fb5e00b1a6f0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/css/css_dmGT3vzMbuQEYT4GrtSmlKGvHMg3EMN2fdyDplKSdzU.css
pragma
no-cache
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
text/css,*/*;q=0.1
cache-control
no-cache
sec-fetch-dest
style
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:20 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
400453
cf-polished
origSize=8304
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
x-request-id
v-7fab0dd6-174b-11ec-b218-d32c911cd3a3
x-robots-tag
noindex, nofollow
last-modified
Fri, 17 Sep 2021 00:09:15 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
692498f32aed21ab-DUS
expires
Fri, 01 Oct 2021 00:09:17 GMT
css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
www.fiercepharma.com/sites/fiercepharma/files/css/
605 KB
55 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7533826884f96d6479ad16c923fb9ad6d9dad65930f9e3a4a5c82ebcdfd92f5c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
pragma
no-cache
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
text/css,*/*;q=0.1
cache-control
no-cache
sec-fetch-dest
style
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:20 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
400453
cf-polished
origSize=627000
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
x-request-id
v-7643daa2-174b-11ec-8d4b-b7f2c3b494c8
x-robots-tag
noindex, nofollow
last-modified
Fri, 17 Sep 2021 00:09:01 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
692498f32aee21ab-DUS
expires
Fri, 01 Oct 2021 00:09:01 GMT
questex.js
cdn.blueconic.net/
139 KB
42 KB
Script
General
Full URL
https://cdn.blueconic.net/questex.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.193.97 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-193-97.fra2.r.cloudfront.net
Software
- /
Resource Hash
cd33d0c53a9b2d35a4377f74c892f6edd0b7fd5889631b92601cc1a757f4c2e8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:12:19 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-permitted-cross-domain-policies
master-only
age
251
x-edge-origin-shield-skipped
0
x-cache
Hit from cloudfront
content-length
41966
x-xss-protection
1; mode=block
last-modified
Fri, 17 Sep 2021 00:31:43 GMT
server
-
etag
"22d0f-5cc260e43bc68-gzip"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
via
1.1 37c215a6cf8b04439db2f97a633421e6.cloudfront.net (CloudFront)
cache-control
public, max-age=600, s-maxage=500
x-amz-cf-pop
FRA2-C1
accept-ranges
none
x-robots-tag
noindex, nofollow
x-amz-cf-id
TTtUL75046_OcLreNfk1PgiwyP5EKjG6YcLZjcaYu6m2l5fhJeRwtQ==
logo-pharma.svg
www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.03
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5f18dc38e84dbadb36b6e7d6da27e45e6fdf4c41ddac6a53452503922e96a73a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.03
pragma
no-cache
cookie
last_visit_bc=1632240981091
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
image/avif,image/webp,image/apng,image/svg+xml,image/*,*/*;q=0.8
cache-control
no-cache
sec-fetch-dest
image
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
x-cache
HIT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
x-request-id
v-5ae8aea4-0dff-11ec-812b-5f1c436fd318
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:21:12 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
692498f3ecf721ab-DUS
expires
Sun, 19 Sep 2021 04:11:33 GMT
remdesivirvial.jpeg
qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1631891062/remdesivirvial.jpeg/
20 KB
21 KB
Image
General
Full URL
https://qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1631891062/remdesivirvial.jpeg/remdesivirvial.jpeg?VersionId=jKjPJqFhHN8bYLBBaaTrnNwpE87oG71H&itok=tIJUPSuP
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.16.92.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cc971927254c785de9f2ebfd5447c658406cac08ed66ffd6daceabde3cf3f89b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
cf-cache-status
HIT
age
345331
cf-polished
qual=85, origFmt=jpeg, origSize=108148
x-amz-replication-status
PENDING
content-length
20938
content-disposition
inline; filename="remdesivirvial.webp"
x-amz-request-id
RZ5SPZ6ZKA7EC3EX
x-amz-id-2
QRL3OBq11zWWId/N/lQVpntcrXuVCVw8xfLECaFk3ab0W/KBa3yxm/zLfWyjY5vCndJdqW3Idk4=
last-modified
Fri, 17 Sep 2021 15:15:41 GMT
server
cloudflare
etag
"b92cd56fc9456df7d1420efc9f8777c3"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
content-type
image/webp
cache-control
public, max-age=604800
x-amz-version-id
jKjPJqFhHN8bYLBBaaTrnNwpE87oG71H
accept-ranges
bytes
cf-ray
692498f41f162163-DUS
cf-bgj
imgq:85,h2pri
kdunleavy_260-3.jpg
qtxasset.com/field/image/
11 KB
11 KB
Image
General
Full URL
https://qtxasset.com/field/image/kdunleavy_260-3.jpg?VersionId=CUUmLzQDpVCEn9t7i2Ze9CgzdykJVjPW
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.16.92.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f2a2e03cfa6b1581e0118a530802959d83e5985aeea14a78e3e31afd15ddd32c

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
cf-cache-status
HIT
age
382689
cf-polished
qual=85, origFmt=jpeg, origSize=55300
cf-ray
692498f41f182163-DUS
content-disposition
inline; filename="kdunleavy_260-3.webp"
content-length
10902
x-amz-id-2
cEUSKnQ4kuqslb/mubOm97FVwxrvKdF2XZ3NYuc8z8y/RDwbOo7NDZTVMCh647pDpxstTpQfUzc=
last-modified
Wed, 31 Mar 2021 19:19:08 GMT
server
cloudflare
etag
"1ab6f9456b300ae44619d8f9069b999c"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept
x-amz-request-id
2EN2YXD1CANT8E7G
cache-control
public, max-age=604800
x-amz-version-id
CUUmLzQDpVCEn9t7i2Ze9CgzdykJVjPW
accept-ranges
bytes
content-type
image/webp
cf-bgj
imgq:85,h2pri
questex-logo-white.svg
www.fiercepharma.com/themes/custom/tektite/assets/images/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/images/questex-logo-white.svg?v=0.1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
680030a41d9b8dcd5edc79e159a420da353dd6638a041a6db69eb0df8b5073b2
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/themes/custom/tektite/assets/images/questex-logo-white.svg?v=0.1
pragma
no-cache
cookie
last_visit_bc=1632240981091
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
image/avif,image/webp,image/apng,image/svg+xml,image/*,*/*;q=0.8
cache-control
no-cache
sec-fetch-dest
image
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
x-cache
HIT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
x-request-id
v-5ae8d3c0-0dff-11ec-b7cb-77187dcab839
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:20:54 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
692498f3ecf921ab-DUS
expires
Sun, 19 Sep 2021 04:11:33 GMT
hb_302826_6936.js
player.mediafuse.com/prebidlink/453400/
394 KB
123 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx/1.18.0 /
Resource Hash
d7b2453833645964e9bb9b2b2e4dd82eaa51bf6f9b7aa9c857e8b17211886a54

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
last-modified
Fri, 17 Sep 2021 13:18:40 GMT
server
nginx/1.18.0
etag
W/"614495b0-629a2"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 21 Sep 2021 17:16:21 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
73 KB
25 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s53-in-f2.1e100.net
Software
sffe /
Resource Hash
d787d4ee6b3b73aae9ea1ce8aeabb759a3038a2ec9e0fae901a958fa5edbd679
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"993 / 345 of 1000 / last-modified: 1632222456"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
25044
x-xss-protection
0
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Tue, 21 Sep 2021 16:16:21 GMT
wrapper_hb_302826_6936.js
player.mediafuse.com/prebidlink/453400/
85 KB
27 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx/1.18.0 /
Resource Hash
e313c730dcdeb89c9c26e893f332a82cf764d61fc564a9b60dbb081bc6ba9c0a

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
last-modified
Fri, 17 Sep 2021 13:17:22 GMT
server
nginx/1.18.0
etag
W/"61449562-15201"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 21 Sep 2021 17:16:21 GMT
gtm.js
www.googletagmanager.com/
152 KB
53 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.16.136 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra15s46-in-f8.1e100.net
Software
Google Tag Manager /
Resource Hash
320147ea3a4898ab2d77393d503ba7416b9ef6e5eee4351d6506458adb92ae5a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
53676
x-xss-protection
0
last-modified
Tue, 21 Sep 2021 15:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Tue, 21 Sep 2021 16:16:21 GMT
js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
www.fiercepharma.com/sites/fiercepharma/files/js/
87 KB
31 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b541d631712bc34f7472aabf9cdeaf0fcb2257fd2436ffced1530f5d4f5a0383
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/js/js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
pragma
no-cache
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
*/*
cache-control
no-cache
sec-fetch-dest
script
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
cf-polished
origSize=89478
x-cache
HIT
last-modified
Thu, 02 Sep 2021 20:58:12 GMT
x-cache-hits
3
x-ah-environment
prod
content-encoding
br
x-request-id
v-27f03586-0f89-11ec-9bc6-938140d6b743
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
692498f36ba421ab-DUS
expires
Tue, 21 Sep 2021 03:10:29 GMT
js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
www.fiercepharma.com/sites/fiercepharma/files/js/
16 KB
7 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8111f22e56354c8880315afdd87fe63c7d82284596f7288969247a118accc642
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/js/js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
pragma
no-cache
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
*/*
cache-control
no-cache
sec-fetch-dest
script
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
cf-polished
origSize=16281
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
x-request-id
v-76187e78-10ea-11ec-b13d-2bfbcfb26011
x-robots-tag
noindex, nofollow
last-modified
Thu, 02 Sep 2021 20:58:12 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
692498f3ac4321ab-DUS
expires
Wed, 22 Sep 2021 21:19:33 GMT
page.js
static.addtoany.com/menu/
84 KB
29 KB
Script
General
Full URL
https://static.addtoany.com/menu/page.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.39.148 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f909a31bfd7a13b9dd53e98b5652f13f4782fdfd1653dc4befade7386c087371
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
e4s
x-content-type-options
nosniff
cf-cache-status
HIT
age
31898
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
last-modified
Fri, 14 May 2021 06:41:59 GMT
server
cloudflare
etag
W/"14f2c-5c2448a7281f2"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=172800
cf-ray
692498f40e248749-DUS
cf-bgj
minify
js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
www.fiercepharma.com/sites/fiercepharma/files/js/
21 KB
7 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9b17ed6f201a539d617120eb2b829a3a32a661daf2f04893c5978b25dd781034
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
pragma
no-cache
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
*/*
cache-control
no-cache
sec-fetch-dest
script
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
cf-polished
origSize=21128
x-cache
HIT
last-modified
Thu, 02 Sep 2021 20:58:13 GMT
x-cache-hits
7
x-ah-environment
prod
content-encoding
br
x-request-id
v-07ffd4d8-0c83-11ec-8ec1-9f4a16496250
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
692498f3bc7321ab-DUS
expires
Fri, 17 Sep 2021 06:49:05 GMT
webfont.js
ajax.googleapis.com/ajax/libs/webfont/1.6.26/
13 KB
6 KB
Script
General
Full URL
https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.184.202 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s11-in-f10.1e100.net
Software
sffe /
Resource Hash
81016ac6be850b72df5d4faa0c3cec8e2c1b0ba0045712144a6766adfad40bee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 14:34:26 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
6115
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/hosted-libraries-pushers
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
5437
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 19:15:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"hosted-libraries-pushers","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/hosted-libraries-pushers"}]}
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="hosted-libraries-pushers"
expires
Wed, 21 Sep 2022 14:34:26 GMT
js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
www.fiercepharma.com/sites/fiercepharma/files/js/
762 B
412 B
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
19d8552b92ae03e066893a9d818a5336bd0d107812dff3c05daef636d8750d38
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/js/js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
pragma
no-cache
cookie
last_visit_bc=1632240981091
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
*/*
cache-control
no-cache
sec-fetch-dest
script
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
cf-polished
origSize=763
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
x-request-id
v-754d5d10-10ea-11ec-b30f-076c28aa3be5
x-robots-tag
noindex, nofollow
last-modified
Thu, 02 Sep 2021 20:58:13 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
692498f3ecfa21ab-DUS
expires
Wed, 22 Sep 2021 21:19:31 GMT
forms2.min.js
app-sj10.marketo.com/js/forms2/js/
205 KB
68 KB
Script
General
Full URL
https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.92.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2689a0237a95cfd8135f8da3ac79c430e903f3c542f8b862f68141c84c348c43
Security Headers
Name Value
Strict-Transport-Security max-age=63113904
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
last-modified
Tue, 10 Aug 2021 17:41:08 GMT
server
cloudflare
age
4216
etag
"a20178-33210-5c93801bbf500"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=63113904
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=14400
cf-ray
692498f419ccc4c2-DUS
vary
Accept-Encoding
expires
Tue, 21 Sep 2021 20:16:21 GMT
js_SAVbbVaruPD0zkfsy-MwQLXZnQ6Lbcicc54DTT-7e04.js
www.fiercepharma.com/sites/fiercepharma/files/js/
5 KB
2 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_SAVbbVaruPD0zkfsy-MwQLXZnQ6Lbcicc54DTT-7e04.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8ba1802771d9ea1b704d1179b94051e114edacf81bafbfa559c6a50dbe013ecd
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/sites/fiercepharma/files/js/js_SAVbbVaruPD0zkfsy-MwQLXZnQ6Lbcicc54DTT-7e04.js
pragma
no-cache
cookie
last_visit_bc=1632240981091
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
*/*
cache-control
no-cache
sec-fetch-dest
script
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
cf-polished
origSize=5137
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
x-request-id
v-7619a9c4-10ea-11ec-ae58-1ba65abcb0c2
x-robots-tag
noindex, nofollow
last-modified
Thu, 02 Sep 2021 20:58:13 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
692498f3ecf621ab-DUS
expires
Wed, 22 Sep 2021 21:19:33 GMT
qFdH35WCmI96Ajtm81GlU9s.woff2
fonts.gstatic.com/s/overpass/v5/
20 KB
20 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v5/qFdH35WCmI96Ajtm81GlU9s.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.74.195 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s02-in-f3.1e100.net
Software
sffe /
Resource Hash
a4702a77ebe38f4291b9ec9f44411e246c865bdf0070746852e803b4d960fc1c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Sun, 19 Sep 2021 14:36:39 GMT
x-content-type-options
nosniff
age
178782
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20196
x-xss-protection
0
last-modified
Thu, 10 Sep 2020 17:08:51 GMT
server
sffe
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 19 Sep 2022 14:36:39 GMT
cs
questex.blueconic.net/DG/DEFAULT/
16 B
704 B
Script
General
Full URL
https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json878
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.234.170.180 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-234-170-180.compute-1.amazonaws.com
Software
- /
Resource Hash
0343964aa4a32ab4c3754c8e7387dc859d2dd70292493ff2b88aa707f037d311
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
-
x-robots-tag
noindex, nofollow
p3p
policyref="", CP="DSP"
x-permitted-cross-domain-policies
master-only
cache-control
no-cache, no-store, no-transform, must-revalidate, private
content-type
text/javascript; charset=utf-8
content-length
36
x-xss-protection
1; mode=block
expires
Thu, 01 Jan 1970 00:00:00 GMT
qFdA35WCmI96Ajtm81keds7N4ho.woff2
fonts.gstatic.com/s/overpass/v5/
20 KB
20 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v5/qFdA35WCmI96Ajtm81keds7N4ho.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.74.195 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s02-in-f3.1e100.net
Software
sffe /
Resource Hash
832d8d5a3cabdde474e79d8a510053604d5d19342befbc7b78dc64995652dbba
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Sun, 19 Sep 2021 14:42:06 GMT
x-content-type-options
nosniff
age
178455
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20252
x-xss-protection
0
last-modified
Thu, 10 Sep 2020 17:09:41 GMT
server
sffe
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Mon, 19 Sep 2022 14:42:06 GMT
qFdA35WCmI96Ajtm81kmdM7N4ho.woff2
fonts.gstatic.com/s/overpass/v5/
20 KB
21 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v5/qFdA35WCmI96Ajtm81kmdM7N4ho.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.74.195 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s02-in-f3.1e100.net
Software
sffe /
Resource Hash
a61ad9d1915814d7822ac27ef8d1e98af9dac45f44297dee24bd0a30bd0b526f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Wed, 15 Sep 2021 08:53:13 GMT
x-content-type-options
nosniff
age
544988
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20836
x-xss-protection
0
last-modified
Thu, 10 Sep 2020 17:07:16 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Thu, 15 Sep 2022 08:53:13 GMT
qFdB35WCmI96Ajtm81GgY9nqxw.woff2
fonts.gstatic.com/s/overpass/v5/
21 KB
21 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v5/qFdB35WCmI96Ajtm81GgY9nqxw.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.74.195 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s02-in-f3.1e100.net
Software
sffe /
Resource Hash
19e011d9a556628501b1557416b8af87442f7baf56cd957a1561d3075c6404c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Wed, 15 Sep 2021 09:01:32 GMT
x-content-type-options
nosniff
age
544489
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
21248
x-xss-protection
0
last-modified
Thu, 10 Sep 2020 17:06:48 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Thu, 15 Sep 2022 09:01:32 GMT
fontello.woff2
www.fiercepharma.com/themes/custom/tektite/assets/fonts/
6 KB
7 KB
Font
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/fonts/fontello.woff2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1daf67a5a85e55210b5e212a8be8392f1f93c01ce54effd63eab78f0b80dfb44
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

sec-fetch-mode
cors
origin
https://www.fiercepharma.com
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
sec-fetch-dest
font
cookie
last_visit_bc=1632240981091
:path
/themes/custom/tektite/assets/fonts/fontello.woff2
pragma
no-cache
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept
*/*
cache-control
no-cache
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
:scheme
https
sec-fetch-site
same-origin
:method
GET
Referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1098488
x-cache
HIT
x-cache-hits
630
x-ah-environment
prod
content-length
6644
x-request-id
v-8737661e-ea08-11eb-bfcb-7f309621aecb
x-robots-tag
noindex, nofollow
last-modified
Sat, 26 Jun 2021 01:06:22 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
cache-control
max-age=1209600
accept-ranges
bytes
cf-ray
692498f3fd1221ab-DUS
expires
Sun, 12 Sep 2021 12:41:10 GMT
asyncPixelSync
pixel.sitescout.com/dmp/ Frame 9232
Redirect Chain
  • https://pixel-a.basis.net/dmp/asyncPixelSync
  • https://pixel.sitescout.com/dmp/asyncPixelSync
  • https://pixel.sitescout.com/dmp/asyncPixelSync?cookieQ=1
1 KB
2 KB
Document
General
Full URL
https://pixel.sitescout.com/dmp/asyncPixelSync?cookieQ=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
66.155.71.149 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash
c0a96907ffc21c092c27dfc837b862b80fd42ce93a68b362d83eaac1f54758c7

Request headers

:method
GET
:authority
pixel.sitescout.com
:scheme
https
:path
/dmp/asyncPixelSync?cookieQ=1
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept-language
de-DE,de;q=0.9
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.fiercepharma.com/
accept-encoding
gzip, deflate, br
cookie
ssi=230359ab-c1dc-4e63-a7cf-13805c1202b9#1632240981258
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038

Response headers

cache-control
max-age=0,no-cache,no-store
pragma
no-cache
expires
Tue, 11 Oct 1977 12:34:56 GMT
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
set-cookie
ssi=230359ab-c1dc-4e63-a7cf-13805c1202b9#1632240981258; Domain=.sitescout.com; Expires=Wed, 21-Sep-2022 16:16:21 GMT; Path=/; Secure; SameSite=None _ssuma=eyIzNCI6MTYzMjI0MDk4MTI4MiwiMiI6MTYzMjI0MDk4MTI4MiwiNCI6MTYzMjI0MDk4MTI4MiwiMzkiOjE2MzIyNDA5ODEyODIsIjciOjE2MzIyNDA5ODEyODJ9; Domain=.sitescout.com; Expires=Thu, 21-Oct-2021 16:16:21 GMT; Path=/; Secure; SameSite=None
content-type
text/html;charset=UTF-8
content-length
1139
date
Tue, 21 Sep 2021 16:16:20 GMT
server
AC1.1

Redirect headers

set-cookie
ssi=abdac9e6-4334-4630-a842-1e413c8a2ff6#1632240981260; Domain=.sitescout.com; Expires=Wed, 21-Sep-2022 16:16:21 GMT; Path=/; Secure; SameSite=None
location
https://pixel.sitescout.com/dmp/asyncPixelSync?cookieQ=1
content-length
0
date
Tue, 21 Sep 2021 16:16:20 GMT
server
AC1.1
7f1874304d399254
pixel.sitescout.com/iap/
Redirect Chain
  • https://pixel-a.basis.net/iap/7f1874304d399254
  • https://pixel.sitescout.com/iap/7f1874304d399254
  • https://pixel.sitescout.com/iap/7f1874304d399254?cookieQ=1
0
341 B
Image
General
Full URL
https://pixel.sitescout.com/iap/7f1874304d399254?cookieQ=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
66.155.71.149 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:20 GMT
cache-control
max-age=0,no-cache,no-store
server
AC1.1
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
expires
Tue, 11 Oct 1977 12:34:56 GMT

Redirect headers

location
https://pixel.sitescout.com/iap/7f1874304d399254?cookieQ=1
date
Tue, 21 Sep 2021 16:16:21 GMT
server
AC1.1
content-length
0
newsletter-signup-bg.svg
www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/
2 KB
666 B
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/newsletter-signup-bg.svg
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

:path
/themes/custom/tektite_fierce/assets/images/newsletter-signup-bg.svg
pragma
no-cache
cookie
last_visit_bc=1632240981091
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
no-cors
accept
image/avif,image/webp,image/apng,image/svg+xml,image/*,*/*;q=0.8
cache-control
no-cache
sec-fetch-dest
image
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1104388
x-cache
HIT
x-cache-hits
9
x-ah-environment
prod
content-encoding
br
x-request-id
v-280e4030-0f89-11ec-82e1-bf197a4d483d
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:21:12 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
692498f42d6521ab-DUS
expires
Tue, 21 Sep 2021 03:10:29 GMT
p.js
d1z2jf7jlzjs58.cloudfront.net/
930 B
1 KB
Script
General
Full URL
https://d1z2jf7jlzjs58.cloudfront.net/p.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.194.156 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-194-156.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
62f586be8571b23584eb4a60a45a3157ff7c8388b1b1e3b4e8890e243b3e47de

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Pragma
public
Date
Tue, 21 Sep 2021 02:28:00 GMT
Via
1.1 ba5b5e2e7fd98c4a472633bc4c1d4480.cloudfront.net (CloudFront)
Connection
keep-alive
Last-Modified
Wed, 06 May 2020 20:19:48 GMT
Server
nginx
Age
49702
ETag
"5eb31be4-3a2"
X-Cache
Hit from cloudfront
Content-Type
application/javascript
Cache-Control
max-age=86400, public
X-Amz-Cf-Pop
FRA2-C1
Content-Length
930
X-Amz-Cf-Id
PYf5h7iqFitK7wBtO9rKOG-l-hPLzLI1hb1sqAPyAmMforKD_AQYjA==
Expires
Wed, 22 Sep 2021 02:27:59 GMT
truncated
/
34 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1e85ec81b9800b4c443d39caca0d0926089a3ac201120db1ceb45b93789480b8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Content-Type
image/gif
getForm
app-sj10.marketo.com/index.php/form/
8 KB
2 KB
Script
General
Full URL
https://app-sj10.marketo.com/index.php/form/getForm?munchkinId=294-MQF-056&form=12997&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients&callback=jQuery112405524613783905166_1632240981235&_=1632240981236
Requested by
Host: app-sj10.marketo.com
URL: https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.92.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b6d5c9dcdbf8b72ed7671ad83c337d8d36d45808f241f7f3636c49a3ea746cd3

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/javascript; charset=utf-8
cf-ray
692498f4db46c4c2-DUS
cached
true
7c3.js
sync.medidexs.com/ps/10/
48 KB
18 KB
Script
General
Full URL
https://sync.medidexs.com/ps/10/7c3.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.1 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx/1.18.0 /
Resource Hash
8ce726b04c9b2ab27be0f6b238c8f3c4c7678781c3921daed4266b4ccf218a6f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
last-modified
Tue, 21 Sep 2021 15:08:19 GMT
server
nginx/1.18.0
etag
W/"6149f563-bfe3"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Tue, 21 Sep 2021 17:16:21 GMT
170
a.ad.gt/api/v1/u/matches/
3 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/170
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.163.47.212 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-163-47-212.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
dfe93d7d93d8451fcf82e24fe974e2c56c034f550b7e341684d5d72719cc46ed

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
server
nginx/1.18.0
content-length
3356
content-type
application/javascript
init-1016mnvd6jvjr44ajs9g.js
api.fouanalytics.com/api/
476 B
977 B
Script
General
Full URL
https://api.fouanalytics.com/api/init-1016mnvd6jvjr44ajs9g.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.200.52 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4fcc6ead9577d358d15d1777368453472824acea19b0c5f2fabd7dfbdd326dd9

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=QOs3RECsppVIXxz%2BRlYNhcICuX%2FjA%2F6sH9Tu24GP8PfXbESiGo9haMOzGBIT1yuBBW1tTfy6oNLJcejdSU68lK57k7%2B3XNuzJYlTsWNhFJMS1FnARWtcNxDZkI0dEoA2RKaVuIgDkA%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
cache-control
no-cache, no-store, must-revalidate
cf-ray
692498f538f039cf-CDG
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
expires
-1
/
hb.mediafuse.com/geo/
135 B
391 B
XHR
General
Full URL
https://hb.mediafuse.com/geo/
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
ddaca1d4b1a403b6659b90b027a3a08e5aefd730f6def3fa0057b731654ffa4c

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 21 Sep 2021 16:16:20 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
135
Content-Type
application/json
tracking
hb.mediafuse.com/adunit/
43 B
420 B
XHR
General
Full URL
https://hb.mediafuse.com/adunit/tracking?event=11&type=0&client_id=302826&site_id=6936&full_page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&adid=ua4xjr.aa&vpbv=0835&lifecycle_tte=1240
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 21 Sep 2021 16:16:20 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
icons.29.svg.js
static.addtoany.com/menu/svg/
78 KB
33 KB
Script
General
Full URL
https://static.addtoany.com/menu/svg/icons.29.svg.js
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.67.39.148 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e30f848c353b8ab801c18d2109527cb32a27f145262dccb3cd4db9f309cc53bb
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
e1s
x-content-type-options
nosniff
cf-cache-status
HIT
age
13113528
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
last-modified
Mon, 31 Dec 2018 23:29:11 GMT
server
cloudflare
etag
W/"13937-57e59c7b88bd6"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
max-age=315360000, immutable
cf-ray
692498f4ff9d8749-DUS
cf-bgj
minify
p.js
cdn.parsely.com/keys/fiercepharma.com/
47 KB
18 KB
Script
General
Full URL
https://cdn.parsely.com/keys/fiercepharma.com/p.js
Requested by
Host: d1z2jf7jlzjs58.cloudfront.net
URL: https://d1z2jf7jlzjs58.cloudfront.net/p.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.225.85.39 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-225-85-39.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
e1feaafecf95d6dfa9fd5dc4ade49fcb29c6a697c713e423940b83e00ae3ad35

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
public
date
Tue, 21 Sep 2021 07:16:57 GMT
content-encoding
gzip
last-modified
Fri, 02 Jul 2021 02:33:20 GMT
server
nginx
age
32364
etag
W/"60de7af0-bd27"
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 edfd22ec6695cdc9d7ac634220af1315.cloudfront.net (CloudFront)
cache-control
max-age=86400, public
x-amz-cf-pop
FRA2-C2
x-amz-cf-id
olwi4faVqdvgkt8-ZNKRq4QSmesj4SaLw-zNK0cOzxH0NDt4N51uMA==
expires
Wed, 22 Sep 2021 07:16:57 GMT
pubads_impl_2021091504.js
securepubads.g.doubleclick.net/gpt/
332 KB
116 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s53-in-f2.1e100.net
Software
sffe /
Resource Hash
f42f55dabbb15175140e8f22510310cbeefe9d766975ce806a9d6f8d9444e66f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
118865
x-xss-protection
0
last-modified
Wed, 15 Sep 2021 18:36:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Tue, 21 Sep 2021 16:16:21 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
39 B
79 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s53-in-f2.1e100.net
Software
cafe /
Resource Hash
2ad9341e45c5e7676ed8925d391b5a96802a29c898d1e4909c4537c0f5a6a2ce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
55
x-xss-protection
0
expires
Tue, 21 Sep 2021 16:16:21 GMT
analytics.js
www.google-analytics.com/
48 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.142 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f14.1e100.net
Software
Golfe2 /
Resource Hash
fd222137f245c06ddb4c4d44db41f12138dad6cf8ef5d4d4a5e500f38f0c8c62
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Wed, 11 Aug 2021 00:32:57 GMT
server
Golfe2
age
5364
date
Tue, 21 Sep 2021 14:46:57 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
19747
expires
Tue, 21 Sep 2021 16:46:57 GMT
4740.js
script.crazyegg.com/pages/scripts/0092/
5 KB
2 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0092/4740.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.148.8 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
daaf47e176780239d864e64b1729d088b9e9a005e19b1bd39fda65dee2e26a6f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
cf-cache-status
HIT
age
348529
cf-polished
origSize=4899
cf-ray
692498f56bd8c4a4-DUS
ce-version
11.1.331
last-modified
Fri, 17 Sep 2021 15:19:23 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
timing-allow-origin
*
cf-bgj
minify
munchkin.js
munchkin.marketo.net/
1 KB
1 KB
Script
General
Full URL
https://munchkin.marketo.net/munchkin.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
23.66.157.159 Central, Hong Kong, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-66-157-159.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
026c5db877da222d2316bf1197b8947a96c7623d51a4d462c91bf927dece3429

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
Last-Modified
Fri, 28 May 2021 01:40:41 GMT
Server
AkamaiNetStorage
ETag
"5379c4a40ff8ae9d2fc6484dd1c57349:1622166041.794746"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
753
dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
s.dpmsrv.com/
124 KB
39 KB
Script
General
Full URL
https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.193.55 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-193-55.fra2.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
da69dd7761d9d27f4f06e2672b6ae1f61730b37ed0fe85a1802652f8d54750e9

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 13:32:04 GMT
Content-Encoding
gzip
Last-Modified
Tue, 14 Sep 2021 13:30:18 GMT
Server
AmazonS3
Age
9857
ETag
"8c5a54fb2f9662bc5b5b0e57474b36f9"
X-Edge-Origin-Shield-Skipped
0
Content-Type
application/x-javascript
Via
1.1 eb83e7e264681d87a86c9b6a2159e502.cloudfront.net (CloudFront)
Connection
keep-alive
X-Cache
Hit from cloudfront
X-Amz-Cf-Pop
FRA2-C1
Accept-Ranges
bytes
Content-Length
39479
X-Amz-Cf-Id
9RJrgvEVQ9SW5GXUWW7f8KxOugms7TIwKX8b-sw7CxzT96KzweQnug==
WgRbL7NLS90BFPSb6pBa
ws.zoominfo.com/pixel/
1 KB
1 KB
Script
General
Full URL
https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.168.82 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / Express
Resource Hash
88944d76219bb324ba3d28ac3981cf303569dd397d2ba6848fc67789c07728ad
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
x-datadome
protected
x-powered-by
Express
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
692498f56a5f2193-DUS
access-control-allow-headers
Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for
via
1.1 google
server
cloudflare
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/
272 KB
74 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
aefe7785628510514a9b8239ce581219565b33e13a778208e8740c4b0b617d80
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Thu, 09 Sep 2021 21:01:42 GMT
Server
Apache
ETag
W/"278709-1631221302000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Tue, 21 Sep 2021 22:16:22 GMT
olytics.css
olytics.omeda.com/olytics/css/v3/p/
28 KB
3 KB
Stylesheet
General
Full URL
https://olytics.omeda.com/olytics/css/v3/p/olytics.css
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Fri, 27 Aug 2021 04:05:28 GMT
Server
Apache
ETag
W/"28820-1630037128000"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Tue, 21 Sep 2021 22:16:22 GMT
tag.aspx
ml314.com/
28 KB
13 KB
Script
General
Full URL
https://ml314.com/tag.aspx?2182021
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
1b05ce33469db78a252caf0e176e3cb56cd4d1d17aa3c3cda89f8088bb3eefda

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:20 GMT
Content-Encoding
gzip
Last-Modified
Tue, 21 Sep 2021 06:52:33 GMT
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public, max-age=52571
Connection
keep-alive
Content-Length
12574
Expires
Wed, 22 Sep 2021 06:52:33 GMT
lead
www.fiercepharma.com/api/v1/marketo/
34 B
391 B
Fetch
General
Full URL
https://www.fiercepharma.com/api/v1/marketo/lead?mkto=null&blueconicProfileId=null
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
336a2c6b0eaf929e5c5be1659be540dcc2cd6df5cc2971ecf4d65480f7505609
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

:path
/api/v1/marketo/lead?mkto=null&blueconicProfileId=null
pragma
no-cache
cookie
last_visit_bc=1632240981091
accept-encoding
gzip, deflate, br
accept-language
de-DE,de;q=0.9
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
sec-fetch-mode
cors
accept
*/*
cache-control
no-cache
sec-fetch-dest
empty
:authority
www.fiercepharma.com
referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
:scheme
https
sec-fetch-site
same-origin
:method
GET
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
75874
x-cache
MISS
content-type
application/json
x-drupal-dynamic-cache
UNCACHEABLE
x-ah-environment
prod
content-encoding
br
x-request-id
v-85d8eb62-1a46-11ec-8bf1-b798621b2b9d
x-ua-compatible
IE=edge
last-modified
Sun, 19 Sep 2021 07:19:15 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
etag
W/"1632035955"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Cookie,Accept-Encoding
content-language
en
x-generator
Drupal 8 (https://www.drupal.org)
cache-control
max-age=43200, public
cf-ray
692498f5484421ab-DUS
x-drupal-cache
HIT
expires
Sun, 19 Nov 1978 05:00:00 GMT
forms2.css
app-sj10.marketo.com/js/forms2/css/
13 KB
3 KB
Stylesheet
General
Full URL
https://app-sj10.marketo.com/js/forms2/css/forms2.css
Requested by
Host: app-sj10.marketo.com
URL: https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.92.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
256e42104f48a5fa80b031da12dc56acde224fba3f9810f8f8192b39136d365a
Security Headers
Name Value
Strict-Transport-Security max-age=63113904
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
3621
vary
Accept-Encoding
content-length
2623
last-modified
Tue, 10 Aug 2021 17:41:08 GMT
server
cloudflare
etag
"1e8019c-3437-5c93801bbf500"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=63113904
content-type
text/css
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
692498f56c5cc4c2-DUS
expires
Tue, 21 Sep 2021 20:16:21 GMT
forms2-theme-simple.css
app-sj10.marketo.com/js/forms2/css/
826 B
327 B
Stylesheet
General
Full URL
https://app-sj10.marketo.com/js/forms2/css/forms2-theme-simple.css
Requested by
Host: app-sj10.marketo.com
URL: https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.92.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
14c8c62dc692fd8faa04434e3fed25e7c23d596b732f9db88f6e9f9ff5dfa61c
Security Headers
Name Value
Strict-Transport-Security max-age=63113904
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
age
3621
vary
Accept-Encoding
content-length
242
last-modified
Tue, 10 Aug 2021 17:41:08 GMT
server
cloudflare
etag
"a201c0-33a-5c93801bbf500"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=63113904
content-type
text/css
cache-control
public, max-age=14400
accept-ranges
bytes
cf-ray
692498f56c60c4c2-DUS
expires
Tue, 21 Sep 2021 20:16:21 GMT
font-awesome.min.css
maxcdn.bootstrapcdn.com/font-awesome/4.1.0/css/
20 KB
5 KB
Stylesheet
General
Full URL
https://maxcdn.bootstrapcdn.com/font-awesome/4.1.0/css/font-awesome.min.css
Requested by
Host: client
URL: about:client
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.10.207 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
br
x-content-type-options
nosniff
cf-cache-status
HIT
cdn-edgestorageid
601, 617
age
13113459
cdn-cachedat
2021-03-10 20:26:40
cdn-pullzone
252412
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
timing-allow-origin
*
access-control-allow-origin
*
last-modified
Mon, 25 Jan 2021 22:04:53 GMT
server
cloudflare
cdn-requestpullcode
200
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
text/css; charset=utf-8
cdn-cache
HIT
vary
Accept-Encoding
cache-control
public, max-age=31919000
cdn-uid
b1941f61-b576-4f40-80de-5677acb38f74
cdn-requestid
f466d24113d3c3cac65aac830c90fb06
cf-ray
692498f58f99c4bd-DUS
cdn-requestcountrycode
DE
cdn-requestpullsuccess
True
/
p1.parsely.com/plogger/
43 B
258 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1632240981348&plid=56325920&idsite=fiercepharma.com&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&urlref=https%3A%2F%2Fgo.questexnetwork.com%2F&screen=1600x1200%7C1600x1200%7C24&data=%7B%7D&sid=1&surl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&sref=https%3A%2F%2Fgo.questexnetwork.com%2F&sts=1632240981344&slts=0&title=Gilead%27s+slumping+COVID-19+drug+takes+another+hit+with+study+showing+no+real+benefit+%7C+FiercePharma&date=Tue+Sep+21+2021+16%3A16%3A21+GMT%2B0000+(GMT)&action=pageview&pvid=94969135&u=pid%3Dfc42f22474ff7de5cd35fe5ce0826f95
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.205.167.202 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-52-205-167-202.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Cache-Control
no-cache
Last-Modified
Tuesday, 21-Sep-2021 16:16:21 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
demconf.jpg
dpm.demdex.net/ Frame 9232
Redirect Chain
  • https://dpm.demdex.net/ibs:dpid=82530&dpuuid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=82530&dpuuid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
42 B
945 B
Image
General
Full URL
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=82530&dpuuid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.171.219.200 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-171-219-200.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://pixel.sitescout.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

DCS
dcs-prod-irl1-1-v016-0c43f75c3.edge-irl1.demdex.com UNKNOWN
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
content-encoding
gzip
X-Content-Type-Options
nosniff
X-TID
qu+Tsm4USt8=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Type
image/gif
Content-Length
59
Expires
Thu, 01 Jan 1970 00:00:00 UTC

Redirect headers

DCS
dcs-prod-irl1-2-v016-0167bd05a.edge-irl1.demdex.com UNKNOWN
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
Q3sUwK06QuA=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Location
https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=82530&dpuuid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 UTC
check
pixel.tapad.com/idsync/ex/receive/ Frame 9232
Redirect Chain
  • https://pixel.tapad.com/idsync/ex/receive?partner_id=2499&partner_device_id=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
  • https://pixel.tapad.com/idsync/ex/receive/check?partner_id=2499&partner_device_id=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
95 B
424 B
Image
General
Full URL
https://pixel.tapad.com/idsync/ex/receive/check?partner_id=2499&partner_device_id=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.227.248.159 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
159.248.227.35.bc.googleusercontent.com
Software
/
Resource Hash
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://pixel.sitescout.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
via
1.1 google
content-type
image/png
alt-svc
clear
content-length
95
strict-transport-security
max-age=31536000
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"

Redirect headers

location
https://pixel.tapad.com/idsync/ex/receive/check?partner_id=2499&partner_device_id=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
date
Tue, 21 Sep 2021 16:16:21 GMT
via
1.1 google
alt-svc
clear
content-length
0
strict-transport-security
max-age=31536000
p3p
policyref="http://tapad-taptags.s3.amazonaws.com/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
/
loadm.exelator.com/load/ Frame 9232
0
324 B
Image
General
Full URL
https://loadm.exelator.com/load/?p=204&g=700&j=0&buid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.254.143.3 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-254-143-3.eu-west-1.compute.amazonaws.com
Software
nginx / Undertow/1
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://pixel.sitescout.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
cache-control
no-cache
access-control-allow-credentials
true
server
nginx
x-powered-by
Undertow/1
p3p
policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA, policyref=/w3c/p3p.xml, CP=NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA
um
sync.teads.tv/ Frame 9232
0
0

tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
bcp.crwdcntrl.net/map/ct=y/c=1389/tp=STSC/ Frame 9232
Redirect Chain
  • https://bcp.crwdcntrl.net/map/c=1389/tp=STSC/tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
  • https://bcp.crwdcntrl.net/map/ct=y/c=1389/tp=STSC/tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
49 B
735 B
Image
General
Full URL
https://bcp.crwdcntrl.net/map/ct=y/c=1389/tp=STSC/tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.253.109.165 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-253-109-165.eu-west-1.compute.amazonaws.com
Software
Jetty(9.4.38.v20210224) /
Resource Hash
2f561b02a49376e3679acd5975e3790abdff09ecbadfa1e1858c7ba26e3ffcef

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://pixel.sitescout.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
server
Jetty(9.4.38.v20210224)
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
access-control-allow-origin
*
cache-control
no-cache
x-server
10.45.6.82
content-type
image/gif
content-length
49
expires
0

Redirect headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
server
Jetty(9.4.38.v20210224)
p3p
CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
location
https://bcp.crwdcntrl.net/map/ct=y/c=1389/tp=STSC/tpid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553
cache-control
no-cache
x-server
10.45.7.27
content-length
0
expires
0
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D360253%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D360253%2526tzOffset%25...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=5735997925621329899&q=xImp&v=1.x&cl=913&pixelIndex=0&r=360253&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffective...
258 B
1007 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=5735997925621329899&q=xImp&v=1.x&cl=913&pixelIndex=0&r=360253&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&_=1632240981366
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.224.43.92 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-224-43-92.compute-1.amazonaws.com
Software
/
Resource Hash
d31b51de2a05eeb3dbe7b0d51de3df006817e2f08f984f90c884486f2ccd9521

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
228
Expires
0

Redirect headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
X-Proxy-Origin
216.131.111.167; 216.131.111.167; 717.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
02fb98e2-0a77-4d53-959d-b4105cae0e4c
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://a.dpmsrv.com/dpmpxl/index.php?id=5735997925621329899&q=xImp&v=1.x&cl=913&pixelIndex=0&r=360253&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&_=1632240981366
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
4740.json
script.crazyegg.com/pages/data-scripts/0092/
10 KB
2 KB
XHR
General
Full URL
https://script.crazyegg.com/pages/data-scripts/0092/4740.json?t=1
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.148.8 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f44cacee437e1a4a3951d3021b0d27b1c8c6d8aaf747e6e03014c4b03dc4c4db

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
cf-cache-status
HIT
age
348526
ce-version
11.1.331
content-length
1499
timing-allow-origin
*
last-modified
Fri, 17 Sep 2021 15:19:23 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
692498f5dbe8215d-DUS
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j93&a=985975207&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&dr=https%3A%2F%2Fgo.questexnetwork.com%2F&ul=en-us&de=UTF-8&dt=Gilead%27s%20slumping%20COVID-19%20drug%20takes%20another%20hit%20with%20study%20showing%20no%20real%20benefit%20%7C%20FiercePharma&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YEBAAAABAAAAAC~&jid=167208221&gjid=1550052318&cid=1519400072.1632240981&tid=UA-336524-28&_gid=869232950.1632240981&_r=1&gtm=2wg9k0KLQFWCZ&z=1001109928
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.142 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f14.1e100.net
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
config.json
player.adtelligent.com/exchange_rates/279934/
9 KB
4 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx/1.18.0 /
Resource Hash
2fbc870d58a2b1e76dfa9c7a5e8e5b21a46a1f62940bae52931acaf3d1e2ef4b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
last-modified
Tue, 21 Sep 2021 12:01:36 GMT
server
nginx/1.18.0
etag
W/"6149c9a0-2240"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
expires
Tue, 21 Sep 2021 17:16:21 GMT
cache-control
max-age=3600
x-proxy-cache
HIT
11.1.331.js
script.crazyegg.com/pages/versioned/common-scripts/
64 KB
21 KB
Script
General
Full URL
https://script.crazyegg.com/pages/versioned/common-scripts/11.1.331.js
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.148.8 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1882996e48b3b800108df06670df431af4a6f9b18eb54f4a74c0d601af52c641

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Wed, 25 Aug 2021 14:00:21 GMT
server
cloudflare
age
349148
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, s-maxage=31536000
accept-ranges
bytes
cf-ray
692498f63d95c4a4-DUS
content-length
21512
877
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

XDFrame
app-sj10.marketo.com/index.php/form/ Frame D4DB
0
0

utsync.ashx
ml314.com/
62 B
572 B
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=undefined&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&pv=1632240981479_fuwvts4it&bl=en-us&cb=412318&return=&ht=&d=&dc=&si=1632240981479_fuwvts4it&cid=&s=1600x1200&rp=https%3A%2F%2Fgo.questexnetwork.com%2F
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2182021
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:20 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
147
Expires
0
ud.ashx
in.ml314.com/
20 B
482 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=2182021
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?2182021
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.226.134.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-134-17.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Wed, 22 Sep 2021 16:16:21 GMT
collect
stats.g.doubleclick.net/j/
1 B
464 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j93&tid=UA-336524-28&cid=1519400072.1632240981&jid=167208221&gjid=1550052318&_gid=869232950.1632240981&_u=YEBAAAAAAAAAAC~&z=98206369
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.251.5.156 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
wg-in-f156.1e100.net
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Tue, 21 Sep 2021 16:16:21 GMT
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
json
gum.criteo.com/sid/ Frame
0
0
Preflight
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&lsw=1
Protocol
H2
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
strict-transport-security
max-age=31536000
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
1584
date
Tue, 21 Sep 2021 16:16:20 GMT
content-encoding
gzip
vary
Accept-Encoding
json
gum.criteo.com/sid/
347 B
627 B
XHR
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&lsw=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
c4b4f8a477e1f3c92ec1644a9e2ffa760b13a3858ca131d9c79eed889649951b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
application/json

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
content-encoding
gzip
date
Tue, 21 Sep 2021 16:16:21 GMT
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
2482
expires
0
auction
prebid.adnxs.com/pbs/v1/openrtb2/
152 B
502 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 Islington, United Kingdom, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
02c6f00a6532bdaf7cfe366bd198cd2d2ab2e9da0aa6f2a9f263db752f00ff6b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
nginx/1.19.0
Vary
Origin
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
152
Expires
0
auction
rtb.adxpremium.services/openrtb2/
324 B
628 B
XHR
General
Full URL
https://rtb.adxpremium.services/openrtb2/auction
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
135.125.163.79 , France, ASN16276 (OVH, FR),
Reverse DNS
ns3190286.ip-135-125-163.eu
Software
/
Resource Hash
cf7c208207a951cf789be1dcfb9fc4fa45462d89e40afe5783ed37d77de89cb3

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
vary
Origin
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
content-length
324
expires
0
mvo
tag.1rx.io/rmp/212473/0/
0
176 B
XHR
General
Full URL
https://tag.1rx.io/rmp/212473/0/mvo?z=1r&hbv=4.41.0-pre,2.1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.19.147.43 , United Kingdom, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
Tengine /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
server
Tengine
trinity.json
apex.go.sonobi.com/
1 KB
3 KB
XHR
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%2223fb1cc7e38914d%22%3A%226af9de6bbe34255426d7%7C970x90%2C970x250%2C970x415%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%22247c4fb46d78112%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%2225afc0ca5127f4d%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%2226e5cb086c883f7%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%2C%2227837da392ec892%22%3A%226af9de6bbe34255426d7%7C1600x1000%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fpharma%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&s=0cc54d5d-f5dd-4858-93a9-d37cfbe2d7fa&pv=4c8a2973-ea95-4b92-8d4b-e769c19a6739&vp=desktop&lib_name=prebid&lib_v=4.41.0-pre&us=0&ius=1&userid=%7B%22pubcid%22%3A%2263c11385-5041-4954-ad53-e44236d05f2c%22%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%2263c11385-5041-4954-ad53-e44236d05f2c%22%2C%22atype%22%3A1%7D%5D%7D%5D&coppa=0
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
178.162.133.150 Rotterdam, Netherlands, ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL),
Reverse DNS
ams-1-apex.go.sonobi.com
Software
sonobi-go /
Resource Hash
cecb3134e5b3ba52c57ae04e147f702d2a88ebffb11f7322c9c5044fe47a8efd
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
Server
sonobi-go
Vary
negotiate,Accept-Encoding
X-Go-Server
apex-ams-1-6-10
P3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, private
Access-Control-Allow-Credentials
true
Tcn
Choice
Content-Type
application/json
Content-Length
755
X-Xss-Protection
0
Expires
Sat, 26 Jul 1997 05:00:00 GMT
prebid-request
onetag-sys.com/
15 B
376 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.251 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip251.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
prebid
prebid.media.net/rtb/
303 B
434 B
XHR
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.148.139 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
139.148.107.34.bc.googleusercontent.com
Software
nginx /
Resource Hash
ad436781cc513db4b51ae89559c5421ce0227273e70b1ba5195016ec1fad8433

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
clear
via
1.1 google
/
ghb.adtelligent.com/v2/auction/
2 KB
663 B
XHR
General
Full URL
https://ghb.adtelligent.com/v2/auction/
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
185.239.173.66 , United Kingdom, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
a6c924fc03e24568ae4d53734da38aabcf7d99aec660c568c6502e37774f5d04

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:20 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
368
adjson
ads.betweendigital.com/
2 B
916 B
XHR
General
Full URL
https://ads.betweendigital.com/adjson?t=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
96.46.186.57 , United States, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
c
prebid.a-mo.net/a/
0
174 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.38.124 Amsterdam, Netherlands, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

x-nbr
1
date
Tue, 21 Sep 2021 16:16:20 GMT
server
envoy
vary
origin, Accept-Encoding
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
x-envoy-upstream-service-time
1
prebid
ib.adnxs.com/ut/v3/
1018 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.240 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
717.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
f1b9c2cc911f7349063d0e15e4c2bc26a854dd72bdf2af86d17c677e53e94ae8
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
216.131.111.167; 216.131.111.167; 717.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
3b39203d-df6a-48f0-bf60-5ec9ec0d75e8
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid
ap.lijit.com/rtb/
25 B
638 B
XHR
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_4.41.0-pre
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
216.52.2.19 , United States, ASN30282 (AS-INAPCDN-OCY, US),
Reverse DNS
Software
nginx /
Resource Hash
28a90aadb5c22faff135da00584afd9b830dded1067dc454612e986db6b7a9db

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Vary
Accept-Encoding, Accept-Encoding, User-Agent
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ad_ap4ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
arj
adtelligent-d.openx.net/w/1.0/
173 B
563 B
XHR
General
Full URL
https://adtelligent-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&ch=UTF-8&res=1600x1200x24&ifr=false&tz=0&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=dc6dfb20-ade5-4e29-81c2-775c8b0961dd%2C1e8800a0-50d8-48df-b1d6-aa9a5093a84a%2Cddcdc59f-da31-4ac7-981e-974923cbf150%2C60c6d7d6-e225-48da-bc22-5d29a93d3726%2Ce5980bf1-bd9b-4912-8572-af38f7406136&nocache=1632240981546&pubcid=63c11385-5041-4954-ad53-e44236d05f2c&schain=1.0%2C1!adtelligent.com%2C302826%2C1%2C%2C%2C&aus=970x90%2C970x250%2C970x415%7C300x600%2C300x250%7C300x600%2C300x250%7C300x600%2C300x250%7C1600x1000&divids=header-ad%2Csidebar-ad%2Csidebar-ad2%2Csidebar-ad3%2Cwallpaper&aucs=%2C%2C%2C%2C&auid=541177132%2C541177132%2C541177132%2C541177132%2C541177132
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.159.8 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
8.159.244.35.bc.googleusercontent.com
Software
OXGW/16.216.0 /
Resource Hash
4ac59813960cff57e86e77a2d0572b41db5f20cefa7758749f33da3625fd9565

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
server
OXGW/16.216.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
clear
content-length
163
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
adreq
ads.servenobid.com/
512 B
568 B
XHR
General
Full URL
https://ads.servenobid.com/adreq?cb=9897
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.228.75.94 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-228-75-94.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
a6942ecf4f00c9c0386d1fd509050be4a4f4247f2d214313e17ad127b027e564

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
/
colossusssp.com/
2 B
247 B
XHR
General
Full URL
https://colossusssp.com/?c=o&m=multi
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_CBC
Server
88.214.207.207 , United Kingdom, ASN46636 (NATCOWEB, US),
Reverse DNS
Software
nginx /
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 21 Sep 2021 16:16:28 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Content-Length
2
Content-Type
application/json
translator
hbopenbid.pubmatic.com/
0
120 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 21 Sep 2021 16:16:20 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
prebid
ib.adnxs.com/ut/v3/
19 B
861 B
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.240 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
717.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
X-Proxy-Origin
216.131.111.167; 216.131.111.167; 717.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
ed2c7896-2606-4b2b-a044-7584dd8b1701
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
19
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44ae0500ac&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
2e57534a870998d111229d916714b55593b33025ad464840d3b8b6025f8f96ba

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44ad1a00b1&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
ae95aebebe48759f966fb35dfc606baafecc3a1ad12bedad254e6194ef11fd98

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
729f27962e75f860eab46d9853fc8a49cfb771349f0cc07defe7da908a0092dc

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
5baa1f22b8a6567727c2c9fe473d214051daf6a86f7d9347d30b0093ab22f09d

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
8d827f9f5d362e46cbfb604b80439d48ada61dc5670d8dc139f367b13c139e3b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
79eb377ce6bceb76026a970e704b7aa754f7290a757e7b07b8d2e877afe69c2f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
3909f3fca633cdc857cbbbf9fe3af90e3e51039e748ff57ec216487b91da304b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
f8c80a13afa0faa19786701dfa52172e99065bf1e625988e6038b431d7fcb466

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
281b85571f7f21480cd64551cffd1f6daf7613b9fee4c21b520d92f3bd52661c

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
fb45b13e87546ec1238f394cee24cdb9b4dc9cbd9cbd50a33ddaa22c536b4624

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
480 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
52.28.203.152 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-28-203-152.eu-central-1.compute.amazonaws.com
Software
ATS/7.1.2.138 /
Resource Hash
d4c24b3912f66537e8b9531aaf4f1e3a4f5b07c0e2c1df021f875f680d47085f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
ATS/7.1.2.138
Age
0
Vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
Access-Control-Allow-Methods
POST,GET,HEAD,OPTIONS
Content-Type
application/json;charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
62
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
2 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=55&alt_size_ids=57&eid_pubcid.org=63c11385-5041-4954-ad53-e44236d05f2c%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&tk_flint=pbjs_lite_v4.41.0-pre&x_source.tid=dc6dfb20-ade5-4e29-81c2-775c8b0961dd&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.44414940459531493
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.61 , United Kingdom, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
2e198425d0be101ff0adca902573d7a19a79c857d29a5f80a85e432b517a04d4

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
2 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=63c11385-5041-4954-ad53-e44236d05f2c%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&tk_flint=pbjs_lite_v4.41.0-pre&x_source.tid=1e8800a0-50d8-48df-b1d6-aa9a5093a84a&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.06571132280188574
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.61 , United Kingdom, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
72e2d9163b9e20de589651265ccca67a06a0da9669460eefa0a2beb354d0c18c

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
2 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=63c11385-5041-4954-ad53-e44236d05f2c%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&tk_flint=pbjs_lite_v4.41.0-pre&x_source.tid=ddcdc59f-da31-4ac7-981e-974923cbf150&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.14343717966732528
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.61 , United Kingdom, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
ac0b0f8dab78f347a060aaf087763913f46dc4109542d6c57ce4308a2fcdb85d

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
2 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=63c11385-5041-4954-ad53-e44236d05f2c%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&tk_flint=pbjs_lite_v4.41.0-pre&x_source.tid=60c6d7d6-e225-48da-bc22-5d29a93d3726&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.3403498124646842
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_GCM
Server
213.19.162.61 , United Kingdom, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
574dfdea32af395d12ab993e5c174666977ee0cbdcecf3431ec4337db3aa685e

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
cdb
bidder.criteo.com/
0
193 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=33&wv=4.41.0-pre&cb=94871963541
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.131 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.am5.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 21 Sep 2021 16:16:21 GMT
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
server
Finatra
timing-allow-origin
*
vary
Origin
prebid.1.1.aspx
inv-nets.admixer.net/
0
0

bids
prebid-us.creativecdn.com/bidder/prebid/
0
182 B
XHR
General
Full URL
https://prebid-us.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.10.30 , Poland, ASN203690 (RTB-HOUSE-ASH, PL),
Reverse DNS
ip-185-184-10-30.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 21 Sep 2021 16:16:21 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
translator
hbopenbid.pubmatic.com/
0
64 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 21 Sep 2021 16:16:20 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
ROS
ads.us.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/
2 B
162 B
XHR
General
Full URL
https://ads.us.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/ROS?rnd=0.2046188175377135&e=970x250_0%3A970x250%2C970x90%2C970x415%2B300x250_0%3A300x250%2C300x600%2B300x250_1%3A300x250%2C300x600%2B300x250_2%3A300x250%2C300x600%2B1600x1000_0%3A1600x1000&ur=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&pbv=4.41.0-pre&ncb=1&vs=FFFFF&crs=UTF-8&fr=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&e_pubcid=63c11385-5041-4954-ad53-e44236d05f2c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
46.249.52.248 , Netherlands, ASN50673 (SERVERIUS-AS, NL),
Reverse DNS
ads.us.e-planning.net
Software
openresty /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Tue, 21 Sep 2021 16:16:21 GMT
access-control-allow-credentials
true
server
openresty
content-type
text/plain
content-length
2
x-sid
AMS-739
integrator.js
adservice.google.de/adsid/
107 B
853 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
570 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
11 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3041297265791970&correlator=874503278526687&output=ldjh&impl=fifs&eid=31060979%2C31061030&vrg=2021091504&ptt=17&sc=1&sfv=1-0-38&ecs=20210921&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=1x1%2C1x1%2C1x1%2C1x1&ists=15&prev_scp=pos%3D4%26hb_rfBid%3D0%7Cpos%3D7%26hb_rfBid%3D0%7Cpos%3D9%26hb_rfBid%3D0%7Cpos%3D8%26hb_rfBid%3D0&eri=1&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D506671%26fm-tester%3Dundefined%26topic%3DCOVID-19%252C%2520Ebola%26keyword%3DGilead%2520Sciences%252C%2520Veklury%252C%2520remdesivir%252C%2520Lancet%252C%2520U.S.%2520FDA%26tag%3DGilead%2520Sciences%252C%2520Veklury%252C%2520remdesivir%252C%2520Lancet%252C%2520U.S.%2520FDA%252CCOVID-19%252C%2520Ebola%252C%26path%3D%252Fpharma%252Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%26browserLargerThan1460%3D1&cookie_enabled=1&bc=31&abxe=1&lmt=1632240980&dt=1632240981575&dlt=1632240980955&idt=491&frm=20&biw=1600&bih=1200&oid=3&adxs=200%2C-12245933%2C800%2C262&adys=24%2C-12245933%2C2784%2C1143&adks=204464188%2C1585981893%2C937470483%2C1373237453&ucis=1%7C2%7C3%7C4&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&ref=https%3A%2F%2Fgo.questexnetwork.com%2F&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1200x0%7C1200x0%7C1600x0%7C710x0&msz=1200x0%7C0x0%7C1600x0%7C710x0&ga_vid=1519400072.1632240981&ga_sid=1632240982&ga_hid=985975207&ga_fc=false&fws=0%2C128%2C0%2C0&ohw=0%2C0%2C0%2C0&btvi=0%7C-1%7C1%7C0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIl0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s53-in-f2.1e100.net
Software
cafe /
Resource Hash
05eede14d1b0df231630154638b6c445f95086558dc2d021db08e4e1a2c201cd
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4620
x-xss-protection
0
google-lineitem-id
4686405525,5630257877,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138234349545,138362896189,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame 858F
0
0

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

csyncs
hb.mediafuse.com/
572 B
621 B
XHR
General
Full URL
https://hb.mediafuse.com/csyncs?aid1=535746&aid2=535749&aid3=undefined
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
18dda3fa8bd592f1e8f20307acb49711ce0a723d28fc3e740538cd4a144fed4b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Date
Tue, 21 Sep 2021 16:16:20 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
326
4740.json
script.crazyegg.com/pages/sampling-data-scripts/0092/
800 B
393 B
XHR
General
Full URL
https://script.crazyegg.com/pages/sampling-data-scripts/0092/4740.json?t=453400
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.331.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.19.148.8 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b109aa01643584538e73bdace10ac6836329a4b020210a8ef41df7ac4b203889

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
cf-cache-status
HIT
age
11895
ce-version
11.1.331
content-length
300
timing-allow-origin
*
last-modified
Tue, 21 Sep 2021 12:45:22 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
692498f70ee9215d-DUS
pp.js
api-34-211-87-144.b2c.com/s/
13 KB
5 KB
Script
General
Full URL
https://api-34-211-87-144.b2c.com/s/pp.js
Requested by
Host: go.questexnetwork.com
URL: https://go.questexnetwork.com/dc/XjvPmlMQLdvXb2RwPN59N4wvtvL4JBERsBQV-Zwa6ZE08W2pDsJ-wmOKyo6Ps4x_O0mDH0Mr5NiFMr8kaJnPqHQHpWyFW5yogHkv6RT-ZfUT_mZrgbpwWF42u5HxdWv6qInGO0ocppgxzHTl3qDGk2YazJfSQpSAzu5Kcskd5hCuV9AbfoJ3iKQW2_SWx_ubk4o0mvtuzkVQD9tHsat4SYLN1gBgfjGJvHqQJjwdLNs=/Mjk0LU1RRi0wNTYAAAF_lJnukJiBgedRiIhIvNYOjTmAobB50cNe_NdeO3ddH-Tj7rOC_xTH3i05KOEYk_bGAnFX0tk=
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.26.7.35 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ebc49e883a573dd0f1ee42a9c60d8a01420005131962dc533bad78f10a91f4d8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 23 Aug 2021 19:56:12 GMT
server
cloudflare
age
6791
etag
W/"6123fd5c-3305"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=UzdlGsNXOW1JAC6iwBkqWuUV0Eoykanf51p%2FXsmvDJtfJPKGfpSl5PW60oqgGr5Kr5p6i0gCm7U0vybRGzRjDHvAm5LL8Jo%2B4%2BWJEIX8W0PcR4RQ0IBnW1Pdn0LzngAPdf8iXr7kbYioLZE%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
692498f76cdd658e-LHR
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

clock
tracking.crazyegg.com/
29 B
136 B
XHR
General
Full URL
https://tracking.crazyegg.com/clock?t=1632240981638
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.331.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.73.172.176 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-73-172-176.eu-west-1.compute.amazonaws.com
Software
awselb/2.0 /
Resource Hash
464db77e594c4a27c0045999f846985c69658f13688c9fa49e87baf3ca3e96b2

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 21 Sep 2021 16:16:21 GMT
cache-control
no-store
server
awselb/2.0
content-length
29
content-type
text/plain
universal-tag.js
ads.spotible.com/tag/
0
0

truncated
/
209 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
a7cc862fa321079663a10c74016fb86ed81e9ffbb76b3b0a80ec462e8264f112

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Content-Type
image/png
osd.js
www.googletagservices.com/activeview/js/current/
72 KB
28 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/osd.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
172.217.23.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s45-in-f2.1e100.net
Software
sffe /
Resource Hash
b49f9c1fdfb1d6199509d3d33ceb8c3355f15f8f12f9e97be20c8616d375be7f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27652
x-xss-protection
0
server
sffe
etag
"1632137829538267"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="active-view-scs-read-write-acl"
expires
Tue, 21 Sep 2021 16:16:21 GMT
Cookie set csync
sync.adtelligent.com/ Frame 3227
Redirect Chain
  • https://csync.loopme.me/?redirect=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D319130%26extuid%3D%7Bdevice_id%7D
  • https://sync.adtelligent.com/csync?t=a&ep=319130&extuid=bb66e291-b090-42ef-9d5e-99e0a0cdd854
86 B
547 B
Document
General
Full URL
https://sync.adtelligent.com/csync?t=a&ep=319130&extuid=bb66e291-b090-42ef-9d5e-99e0a0cdd854
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
62.149.0.72 , Ukraine, ASN15497 (COLOCALL Internet Data Center ColoCALL, UA),
Reverse DNS
0-72.cc86365-03-tmp.cc.colocall.com
Software
VertaMedia 1.0 /
Resource Hash
1cc9e0ac0ff231ba3fc0c9c42b40ebcc6c5a3058722ca99eeb0fed41f3efb997

Request headers

Host
sync.adtelligent.com
Connection
keep-alive
Pragma
no-cache
Cache-Control
no-cache
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site
cross-site
Sec-Fetch-Mode
navigate
Sec-Fetch-Dest
iframe
Referer
https://www.fiercepharma.com/
Accept-Encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

Server
VertaMedia 1.0
Date
Tue, 21 Sep 2021 16:16:21 GMT
Content-Type
image/gif
Content-Length
86
Cache-Control
no-cache, no-store, must-revalidate
Set-Cookie
vmuid=81a1960d96ec7b55; expires=Mon, 22 Nov 2021 16:16:21 GMT; domain=.adtelligent.com; path=/; secure; SameSite=None a319130=bb66e291-b090-42ef-9d5e-99e0a0cdd854; expires=Mon, 22 Nov 2021 16:16:21 GMT; domain=.adtelligent.com; path=/; secure; SameSite=None

Redirect headers

set-cookie
viewer_token=bb66e291-b090-42ef-9d5e-99e0a0cdd854; path=/; domain=csync.loopme.me; Expires=Thu, 21-Oct-2021 16:16:21 GMT
location
https://sync.adtelligent.com/csync?t=a&ep=319130&extuid=bb66e291-b090-42ef-9d5e-99e0a0cdd854
content-length
0
date
Tue, 21 Sep 2021 16:16:21 GMT
server
_
1px-matching-adtelligent.gif
t.trafmag.com/images/images/
Redirect Chain
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=81a1960d96ec7b55
35 B
232 B
Image
General
Full URL
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=81a1960d96ec7b55
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
193.200.65.5 Amsterdam, Netherlands, ASN6681 (GIVEME-CLOUD, PL),
Reverse DNS
t.trafmag.com
Software
nginx /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
server
nginx
content-type
image/gif
content-length
35
p3p
CP="NON DSP COR CURa TIA"

Redirect headers

Location
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=81a1960d96ec7b55
Date
Tue, 21 Sep 2021 16:16:21 GMT
Server
VertaMedia 1.0
Content-Length
43
Content-Type
image/gif
match
dm.hybrid.ai/
0
238 B
Image
General
Full URL
https://dm.hybrid.ai/match?id=186&burl=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D324902%26extuid%3D%24%7BVID%7D
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
37.18.16.23 , Netherlands, ASN205675 (HYBRID-AS, RU),
Reverse DNS
Software
Hybrid Web Server /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
server
Hybrid Web Server
p3p
CP="NOI DSP COR CUR ADMa DEVo TAIo PSAo PSDo IVAo IVDo OUR IND COM NAV INT STA OTC"
access-control-allow-origin
*
cache-control
no-cache, no-store
x-mode
106
x-xss-protection
1; mode=block
expires
-1
sodar
pagead2.googlesyndication.com/getconfig/
11 KB
9 KB
XHR
General
Full URL
https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2021091504&st=env
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
cafe /
Resource Hash
ab979f0abc8b8119d48362ec7d18e8b613ec677f99cc76d8d10c6b9a76be7ad8
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
8483
x-xss-protection
0
ad.gif
api-34-211-87-144.b2c.com/api/
43 B
368 B
Image
General
Full URL
https://api-34-211-87-144.b2c.com/api/ad.gif
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.26.7.35 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=kfp%2FEIbpWaI4pISLegKflzMjj2yA%2FI%2FjJWtsWeEMrBkNxJ0wN%2FVxOOiwmX%2BHyMECSN2VnFEVRafkPPVrezsogZKLBymAI0xBeIIX%2FtZNXAdqbEwzHEVkT4MBv1ieDGjdURo%2FUAcOMEpf70U%3D"}],"group":"cf-nel","max_age":604800}
content-type
image/gif
last-modified
Mon, 28 Sep 1970 06:00:00 GMT
cf-ray
692498f7fde5658e-LHR
content-length
43
sodar2.js
tpc.googlesyndication.com/sodar/
17 KB
7 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.181.225 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s56-in-f1.1e100.net
Software
sffe /
Resource Hash
a5ead9037af4a0e749e217f63b25a25493a7705e17d98f04b336ab1370a353db
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:21 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1624308425655142"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
6467
x-xss-protection
0
cross-origin-opener-policy-report-only
same-origin; report-to="adspam-signals-scs"
expires
Tue, 21 Sep 2021 16:16:21 GMT
haloid
aufp.io/api/v1/
6 KB
3 KB
Script
General
Full URL
https://aufp.io/api/v1/haloid
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.223.151.79 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-223-151-79.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
85e50082d7ce113bfa87dbade18dbf747d1bacfcffdbd628296dcffa98a08f94

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
gzip
last-modified
Mon, 20 Sep 2021 19:55:46 GMT
server
nginx/1.18.0
etag
W/"1632167746.0-6132-2958560116"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*, *
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
origin-trial
A/KTxPuSXtwcggydvUxw5B4dXspsb2iweedc7KDi2xv9M89MtnOpULTs7DQJVHBxGDV5wj5a3LW9S4ev3WfQkwIAAAB+eyJvcmlnaW4iOiJodHRwczovL2hhbG9mbG9jLmNvbTo0NDMiLCJmZWF0dXJlIjoiSW50ZXJlc3RDb2hvcnRBUEkiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Wed, 22 Sep 2021 04:16:22 GMT
170
p.ad.gt/api/v1/p/
25 KB
8 KB
Script
General
Full URL
https://p.ad.gt/api/v1/p/170
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.25.225.148 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-25-225-148.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
c193fa47a8ff355952cd825a6d96074f55614a4cc46e4b7046f12a7cf497bee8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
gzip
last-modified
Mon, 20 Sep 2021 19:53:22 GMT
server
nginx/1.18.0
etag
W/"1632167602.0-25886-2710964840"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Wed, 22 Sep 2021 04:16:22 GMT
match
ids.ad.gt/api/v1/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&adnxs_id=$UID
  • https://ids.ad.gt/api/v1/match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&adnxs_id=5735997925621329899
43 B
563 B
Image
General
Full URL
https://ids.ad.gt/api/v1/match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&adnxs_id=5735997925621329899
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:21 GMT
X-Proxy-Origin
216.131.111.167; 216.131.111.167; 719.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
45d1c828-25c3-4faf-b9ad-646d63930974
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://ids.ad.gt/api/v1/match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&adnxs_id=5735997925621329899
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
t_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
  • https://ids.ad.gt/api/v1/t_match?tdid=010e5372-0935-48b5-85bd-1e6e2626ad58&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
43 B
568 B
Image
General
Full URL
https://ids.ad.gt/api/v1/t_match?tdid=010e5372-0935-48b5-85bd-1e6e2626ad58&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:21 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://ids.ad.gt/api/v1/t_match?tdid=010e5372-0935-48b5-85bd-1e6e2626ad58&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
259
pbm_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
  • https://ids.ad.gt/api/v1/pbm_match?pbm=D669AC34-AAD1-4434-8683-EE81A74C2B93&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
43 B
571 B
Image
General
Full URL
https://ids.ad.gt/api/v1/pbm_match?pbm=D669AC34-AAD1-4434-8683-EE81A74C2B93&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/pbm_match?pbm=D669AC34-AAD1-4434-8683-EE81A74C2B93&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
date
Tue, 21 Sep 2021 16:16:20 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
g_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
  • https://ids.ad.gt/api/v1/g_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&google_gid=CAESEGI2Rf67IBhFIcjr05CHMLg&google_cver=1&google_ula=450542624,0
43 B
570 B
Image
General
Full URL
https://ids.ad.gt/api/v1/g_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&google_gid=CAESEGI2Rf67IBhFIcjr05CHMLg&google_cver=1&google_ula=450542624,0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://ids.ad.gt/api/v1/g_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&google_gid=CAESEGI2Rf67IBhFIcjr05CHMLg&google_cver=1&google_ula=450542624,0
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
357
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ids.ad.gt/api/v1/g_hosted?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=YmYzM2MwYzEtN2UwZS00NzE4LWE2YzMtN2NkMTM0ZGJhZGI0
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=YmYzM2MwYzEtN2UwZS00NzE4LWE2YzMtN2NkMTM0ZGJhZGI0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.34 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s04-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=YmYzM2MwYzEtN2UwZS00NzE4LWE2YzMtN2NkMTM0ZGJhZGI0
date
Tue, 21 Sep 2021 16:16:22 GMT
server
nginx/1.18.0
content-length
473
content-type
text/html; charset=utf-8
cm
trc.taboola.com/sg/audigent/1/
43 B
238 B
Image
General
Full URL
https://trc.taboola.com/sg/audigent/1/cm?redirect=http%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Ftaboola%3Fpartner_uid%3D%3CTUID%3E%3Fid%3Dbf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
151.101.193.44 , United States, ASN54113 (FASTLY, US),
Reverse DNS
Software
nginx /
Resource Hash
0d9762a1a60deef8aa093c473ad27c38eed77184d6940e7df06d89d77cbd3e94

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

x-vcl-time-ms
9
pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
via
1.1 varnish
server
nginx
x-timer
S1632240982.071803,VS0,VE9
x-served-by
cache-hhn4071-HHN
x-cache
MISS
cache-control
no-cache, no-store
accept-ranges
bytes
x-cache-hits
0
son_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://sync.go.sonobi.com/us?https://ids.ad.gt/api/v1/son_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&uid=[UID]
  • https://ids.ad.gt/api/v1/son_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&uid=39227249-44c9-4e14-81e2-3aebc2a43cad
43 B
476 B
Image
General
Full URL
https://ids.ad.gt/api/v1/son_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&uid=39227249-44c9-4e14-81e2-3aebc2a43cad
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:22 GMT
Server
sonobi-go
Vary
negotiate,Accept-Encoding
X-Go-Server
xcp-ams-1-7-9
P3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Location
https://ids.ad.gt/api/v1/son_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&uid=39227249-44c9-4e14-81e2-3aebc2a43cad
Cache-Control
no-cache, no-store, private
Tcn
Choice
Content-Type
text/plain; charset=utf8
Content-Length
0
X-Xss-Protection
0
Expires
Sat, 26 Jul 1997 05:00:00 GMT
adb_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://dpm.demdex.net/ibs:dpid=348447&dpuuid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fadb_match%3Fadb%3D%24%7BDD_UUID%7D%26id%3Dbf33c0c1-7e0e-4718-a6c3-7cd13...
  • https://ids.ad.gt/api/v1/adb_match?adb=19663782927819267720830632050847266550&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
43 B
478 B
Image
General
Full URL
https://ids.ad.gt/api/v1/adb_match?adb=19663782927819267720830632050847266550&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

DCS
dcs-prod-irl1-1-v016-07800fea7.edge-irl1.demdex.com UNKNOWN
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
h2YpECwDSsY=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Location
https://ids.ad.gt/api/v1/adb_match?adb=19663782927819267720830632050847266550&id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 UTC
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=5735997925621329899&pixelIndex=0&_=1632240981367
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5735997925621329899&pixelIndex=0&_=1632240981367&google_gid=CAESEN7tM4cFGRweSt1qOrmM_uI&google_cver=1
0
598 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5735997925621329899&pixelIndex=0&_=1632240981367&google_gid=CAESEN7tM4cFGRweSt1qOrmM_uI&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.224.43.92 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-224-43-92.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=5735997925621329899&pixelIndex=0&_=1632240981367&google_gid=CAESEN7tM4cFGRweSt1qOrmM_uI&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
368
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
423396.gif
idsync.rlcdn.com/
0
66 B
Image
General
Full URL
https://idsync.rlcdn.com/423396.gif?partner_uid=5735997925621329899
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.174.68 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
68.174.244.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
via
1.1 google
alt-svc
clear
content-length
0
runner.html
tpc.googlesyndication.com/sodar/sodar2/224/ Frame A3D6
12 KB
5 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/sodar2/224/runner.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.181.225 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s56-in-f1.1e100.net
Software
sffe /
Resource Hash
4fa0156d693856f79289525c8e4db988a188d55ce0283351c96d811c7ce3e2c3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

:method
GET
:authority
tpc.googlesyndication.com
:scheme
https
:path
/sodar/sodar2/224/runner.html
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept-language
de-DE,de;q=0.9
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.fiercepharma.com/
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-length
5029
date
Tue, 21 Sep 2021 14:07:40 GMT
expires
Wed, 21 Sep 2022 14:07:40 GMT
last-modified
Wed, 02 Jun 2021 17:09:45 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
cache-control
public, max-age=31536000
age
7721
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
aframe
www.google.com/recaptcha/api2/ Frame 9A1C
783 B
1 KB
Document
General
Full URL
https://www.google.com/recaptcha/api2/aframe
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.100 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s49-in-f4.1e100.net
Software
GSE /
Resource Hash
a2196b2080c19dcf3bb0aae9dc76ad19c205ef5512e75e0580028f023e1222fa
Security Headers
Name Value
Content-Security-Policy script-src 'report-sample' 'nonce-YfOAHE1gXJjwH18g3Vq55A' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

:method
GET
:authority
www.google.com
:scheme
https
:path
/recaptcha/api2/aframe
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept-language
de-DE,de;q=0.9
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.fiercepharma.com/
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

cross-origin-resource-policy
cross-origin
cross-origin-embedder-policy-report-only
require-corp; report-to="recaptcha"
report-to
{"group":"recaptcha","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/recaptcha"}]}
expires
Tue, 21 Sep 2021 16:16:21 GMT
date
Tue, 21 Sep 2021 16:16:21 GMT
cache-control
private, max-age=300
content-type
text/html; charset=utf-8
content-security-policy
script-src 'report-sample' 'nonce-YfOAHE1gXJjwH18g3Vq55A' 'unsafe-inline' 'strict-dynamic' https: http: 'unsafe-eval';object-src 'none';base-uri 'self';report-uri https://csp.withgoogle.com/csp/recaptcha/1
content-encoding
gzip
x-content-type-options
nosniff
x-xss-protection
1; mode=block
content-length
515
server
GSE
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
csVh-mWMFjsNWXzC6t087cpicS74qrTXodz_eQ5g-pQ.js
pagead2.googlesyndication.com/bg/ Frame A3D6
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/csVh-mWMFjsNWXzC6t087cpicS74qrTXodz_eQ5g-pQ.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2/224/runner.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
sffe /
Resource Hash
72c561fa658c163b0d597cc2eadd3cedca62712ef8aab4d7a1dcff790e60fa94
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 12:35:48 GMT
content-encoding
br
x-content-type-options
nosniff
age
13234
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13281
x-xss-protection
0
last-modified
Wed, 15 Sep 2021 09:28:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="botguard-scs"
expires
Wed, 21 Sep 2022 12:35:48 GMT
integrator.js
adservice.google.de/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.194 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s52-in-f2.1e100.net
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051="googleads.g.doubleclick.net:443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.66 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s05-in-f2.1e100.net
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

timing-allow-origin
*
date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
47 KB
17 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=3041297265791970&correlator=2596441170724863&output=ldjh&impl=fifs&eid=31060979%2C31061030&vrg=2021091504&ptt=17&sc=1&sfv=1-0-38&ecs=20210921&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cpharma&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250%7C970x415%2C300x600%7C300x250%2C300x600%7C300x250%2C300x600%7C300x250%2C1600x1000&prev_scp=pos%3D0%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D1%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D2%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D3%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D5%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DPharma%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D506671%26fm-tester%3Dundefined%26topic%3DCOVID-19%252C%2520Ebola%26keyword%3DGilead%2520Sciences%252C%2520Veklury%252C%2520remdesivir%252C%2520Lancet%252C%2520U.S.%2520FDA%26tag%3DGilead%2520Sciences%252C%2520Veklury%252C%2520remdesivir%252C%2520Lancet%252C%2520U.S.%2520FDA%252CCOVID-19%252C%2520Ebola%252C%26path%3D%252Fpharma%252Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%26browserLargerThan1460%3D1&cookie=ID%3Dbf0e63c8d45b7c74-226adb8643c900c0%3AT%3D1632240981%3AS%3DALNI_MZzOKeeEX-NMKSKPYIRJkHrkqR3bw&bc=31&abxe=1&lmt=1632240980&dt=1632240982001&dlt=1632240980955&idt=491&frm=20&biw=1600&bih=1200&oid=3&adxs=-9%2C-9%2C-9%2C-9%2C-9&adys=-9%2C-9%2C-9%2C-9%2C-9&adks=564636127%2C3263208563%2C2184391133%2C2184391132%2C3786707769&ucis=5%7C6%7C7%7C8%7C9&ifi=5&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&ref=https%3A%2F%2Fgo.questexnetwork.com%2F&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x-1%7C0x-1%7C0x-1%7C0x-1%7C0x-1&msz=0x-1%7C0x-1%7C0x-1%7C0x-1%7C0x-1&psts=AGkb-H8HcsNRhV5tBCCt2JtYyUDTUD9UTclNhXoyEr3j2HSz60MORZjF6IzbwvZrZfof4kNNA19zL-0gcoNvaehqoYjL%2CAGkb-H-DcSKrTrA5J366IqlN6ztHsCsdQDCwHR85o2b6onJMjcoC9Lr_vp-1zfidAbBTYLtgYoy4JlN_TGVUYVRQDb7v%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1519400072.1632240981&ga_sid=1632240982&ga_hid=985975207&ga_fc=false&fws=2%2C2%2C2%2C2%2C2&ohw=0%2C0%2C0%2C0%2C0&btvi=-1%7C-1%7C-1%7C-1%7C-1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIl0.
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s53-in-f2.1e100.net
Software
cafe /
Resource Hash
20cabe8c26414d50bb327e2d2beb3d5086765f8b24191cb9a617cc0b19216064
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
17115
x-xss-protection
0
google-lineitem-id
-2,-2,5786482951,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
-2,-2,138363411175,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
sodar
pagead2.googlesyndication.com/pagead/ Frame 9A1C
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=224&li=gpt_2021091504&jk=3041297265791970&rc=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.google.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

x
api-34-211-87-144.b2c.com/api/
0
623 B
XHR
General
Full URL
https://api-34-211-87-144.b2c.com/api/x?0gLAlGH5olNVmaZ8$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9waGFybWEvbW9yZS1ldmlkZW5jZS1lbWVyZ2VzLWluZWZmZWN0aXZlbmVzcy1naWxlYWQtcy12ZWtsdXJ5LWNvdmlkLTE5LXBhdGllbnRzP21rdF90b2s9TWprMExVMVJSaTB3TlRZQUFBRl9sSm51a0xhRjE4M0NlWHFqNFZEVjBqd2VsdWFPZlgtR2NYakhLdnNSQkZhbmF3VmtfNUNLYk9iRjB4MDZiZFZFU1NJZFVFNEFYQ19qSjZaeWVvSVRQbV84Mkx2MVVKVFFtUkU4RmJTS0NVbWVTd29CbXZJJm1ya2lkPTE3MDczMjAzOCIsInJlZmVycmVyJDAkaHR0cHM6Ly9nby5xdWVzdGV4bmV0d29yay5jb20vIiwiYW5jZXN0b3JPcmlnaW5zJDAkIiwidmlkZW8kMCQxNjAweDEyMDB4MjQiLCJmcmFtZSQwJDAiLCJoaWRkZW4kMCQwIiwidmlzaWJpbGl0eVN0YXRlJDAkdmlzaWJsZSIsImhhc0ZvY3VzJDAkMSIsIndpbmRvdyQwJDE2MDB4MTIwMCIsInBpeGVscmF0aW8kMCQxIiwiaW5uZXIkMCQxNjAweDEyMDAiLCJvdXRlciQwJDE2MDB4MTIwMCIsImxvY2FsU3RvcmFnZSQwJDEiLCJzZXNzaW9uU3RvcmFnZSQwJDEiLCJhcHBDb2RlTmFtZSQwJE1vemlsbGEiLCJhcHBOYW1lJDAkTmV0c2NhcGUiLCJhcHBWZXJzaW9uJDAkNS4wIChXaW5kb3dzIE5UIDEwLjA7IFdpbjY0OyB4NjQpIEFwcGxlV2ViS2l0LzUzNy4zNiAoS0hUTUwsIGxpa2UgR2Vja28pIENocm9tZS85My4wLjQ1NzcuNjMgU2FmYXJpLzUzNy4zNiIsImNvb2tpZUVuYWJsZWQkMCR0cnVlIiwiZG9Ob3RUcmFjayQwJCIsImhhcmR3YXJlQ29uY3VycmVuY3kkMCQ0IiwibGFuZ3VhZ2UkMCRlbi1VUyIsInBsYXRmb3JtJDAkTGludXggeDg2XzY0IiwicHJvZHVjdCQwJEdlY2tvIiwicHJvZHVjdFN1YiQwJDIwMDMwMTA3Iiwic2VuZEJlYWNvbiQwJDEiLCJ1c2VyQWdlbnQkMCRNb3ppbGxhLzUuMCAoV2luZG93cyBOVCAxMC4wOyBXaW42NDsgeDY0KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvOTMuMC40NTc3LjYzIFNhZmFyaS81MzcuMzYiLCJ2ZW5kb3IkMCRHb29nbGUgSW5jLiIsInZlbmRvclN1YiQwJCIsImZvbnRyZW5kZXIkNCQxIiwid2ViZ2wkOSQxIiwid2ViZ2wyJDkkMSIsIndlYmdsLXZlbmRvciQ5JEludGVsIEluYy4iLCJ3ZWJnbC1yZW5kZXJlciQ5JEludGVsIElyaXMgT3BlbkdMIEVuZ2luZSIsIndlYmdsLWV4dGVuc2lvbnMkMTAkNTY4ODI5NjciLCJ0aW1lJDEwJDE2MzIyNDA5ODE3MjEiLCJ0aW1lem9uZSQxMCQwIiwicGx1Z2lucy10aW1lJDEwJDAuMSIsInBsdWdpbnMkMTAkYjZkMDU1NTgiLCJtZW0tdG90YWxKU0hlYXBTaXplJDEwJDIzLjEiLCJtZW0tdXNlZEpTSGVhcFNpemUkMTAkMTcuMSIsIm1lbS1qc0hlYXBTaXplTGltaXQkMTAkMzc2MCIsInRpbWUtcmVkaXJlY3RFbmQkMTAkMzExIiwidGltZS1mZXRjaFN0YXJ0JDEwJDMxMSIsInRpbWUtZG9tYWluTG9va3VwU3RhcnQkMTAkMzExIiwidGltZS1kb21haW5Mb29rdXBFbmQkMTAkMzExIiwidGltZS1jb25uZWN0U3RhcnQkMTAkMzExIiwidGltZS1jb25uZWN0RW5kJDEwJDMxMSIsInRpbWUtcmVxdWVzdFN0YXJ0JDEwJDMxMiIsInRpbWUtcmVzcG9uc2VTdGFydCQxMCQ5MjkiLCJ0aW1lLXJlc3BvbnNlRW5kJDEwJDkzMSIsInRpbWUtZG9tTG9hZGluZyQxMCQ5MzIiLCJ0aW1lLWRvbUludGVyYWN0aXZlJDEwJDEyMzEiLCJ0aW1lLWRvbUNvbnRlbnRMb2FkZWRFdmVudFN0YXJ0JDEwJDEyMzEiLCJ0aW1lLWRvbUNvbnRlbnRMb2FkZWRFdmVudEVuZCQxMCQxMjM3IiwidGltZS1kb21Db21wbGV0ZSQxMCQxNjczIiwibmF2aWdhdGlvbi1yZWRpcmVjdENvdW50JDExJDEiLCJuYXZpZ2F0aW9uLXR5cGUkMTEkbmF2aWdhdGUiLCJnbG9iYWxzLXRpbWUkMjEkMC40IiwiZ2xvYmFscyQyMSRiZjUxNWMxYyIsImRvY3VtZW50LXRpbWUkMjkkMi4zIiwiZG9jdW1lbnQkMjkkYTBlYjExNTAiLCJjb25uZWN0aW9uJDI5JCIsImRvd25saW5rTWF4JDI5JCIsImdldFVzZXJNZWRpYSQzMCQyIiwiYXBwbGVwYXkkMzAkbi9hIiwicGFnZS1mcmFtZS1jb3VudCQzMCQxIiwicGFnZS1mcmFtZS1saXN0JDMwJDB4MCNjc3luYy5sb29wbWUubWUiLCJwYWdlLWhhc2gkMzEkYTJlNmNmY2UiLCJjbG9jayQzNSQ1NTY1IiwiYmF0dGVyeSQzOCQxIDEgMCBJbmZpbml0eSIsInBlcm1pc3Npb24tZ2VvbG9jYXRpb24kMzgkcHJvbXB0IiwiaW50ZXJzZWN0aW9uLXNpemUkMzgkMTYwMHgxMjAwIiwiaW50ZXJzZWN0aW9uLWVudGVyJDM4JDB4MCAxNjAweDAiLCJpbnRlcnNlY3Rpb24kMzgkMTAwIiwicGVybWlzc2lvbi1ub3RpZmljYXRpb25zJDM4JHByb21wdCIsInBlcm1pc3Npb24tY2FtZXJhJDM4JHByb21wdCIsInBlcm1pc3Npb24tbWljcm9waG9uZSQzOCRwcm9tcHQiLCJwZXJtaXNzaW9uLXBlcnNpc3RlbnQtc3RvcmFnZSQzOCRwcm9tcHQiLCJhdWRpb2NvbnRleHQkNDQkZjdlNzEyZDkiLCJzb3J0JDY5JDExLjkiLCJmcmFtZXJhdGUkMTQ2JDkwIiwiYWRibG9jayQyMzYkMA~~
Requested by
Host: api-34-211-87-144.b2c.com
URL: https://api-34-211-87-144.b2c.com/s/pp.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.26.7.35 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
access-control-allow-methods
GET, POST, OPTIONS
content-type
text/plain; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=MpwWMZ780sdN1FkVi7SHAZ52EH%2FOaytSYSPj1DUXp4xIMsIPHfg4XkaSUnewLLZekzkM1FxKkDZeYh1LqMrkmHebCcslBMgRCDNXlD6nr9KngrKt1OfWGlrRfc9N9q4FJzm5xwg%2BE%2FrD2s4%3D"}],"group":"cf-nel","max_age":604800}
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cf-ray
692498fa5b2ae654-LHR
expires
-1
gen_204
pagead2.googlesyndication.com/pagead/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=gfp_cw_status&domain=fiercepharma.com&host=www.fiercepharma.com&success=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2021091504.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
sodar
pagead2.googlesyndication.com/pagead/
0
0
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/sodar?id=sodar2&v=224&t=2&li=gpt_2021091504&jk=3041297265791970&bg=!9_Sl9LDNAAZWaDWkVmg7ACkAdvg8WoWJUTPrubUNybohZ2XXt4qB-I26inPULG_sulJea8jYVFUpmgIAAACGUgAAAApoAQeZAqjIeswSIFcWA0fkFs8GgRDPYyd6psNXHAhfMyhfoRG_bWJkXOV83uSwn4HS3J3DzBbSmtrKa3I0DKq5dFuG6Ab-kRM9lWZYfVRM1txeTr6ZS9r1lWJJfxasd3AFSGnp13Cd60rmS9345JjVZQyoUaFhHH8kit_C9fEIZ890KXSwJXEf3KNpvqcbafWNUwrISUm0-JcPBMBYaoL8l9oOXfIrz5Dy05M4GqwzY5a-x_7iOhVQz6uBcrddrqKpVk2m_1JpEZ8RTe9FAVJxTHBNgnueBjdq7Yq_OLQtuaU0aJcI0Q5LLv-B0Nm1PNgc5Sey06qtUDGRngGh7KueaKCNdugJYBMBHxVa_Mly7Nvm9BYNCC3gu4sQrr_KHyUnYEY0DE_qEjSrKksJ0jyCVfIUcMKJvIP3inxMIyl_lb_H_KKKiq0E5V3bCmMLADqhi8uhLwz3qUz-MveXS95aB-B3jYLQJ6rArlYiOgfHDG_bSmX_L_ksTlHC-uodhwHgc89GqH4UpjTiN76tkrdEO6pJMaT0qntMsiNMzFuMggzOO9-vE7BLaZqffRTuQqEtt0fsoKHsscettWbrQYxvsD-05vhuRwgWOwDGUMVV0-9hZ2mWEbPm9ya4mCfcFkqm7ZxH8WWiKURs0vQWWV8b-XmInvnxPvvBHUwKdnBqPsM1oboCF1n7TSrsRo9trTxf5_jKfDY0R5jDv_VsXKw4nb-Xpx6mwk8BhqfK5EjKJycZt76zrzA3VHGJSARw8vRrZQpgG4jFjmA_1eu9e548_ESuS-4giGXUrqBnp-7IWIQ-Qw3BBW2anXDm67cgkc3xGzRgJO4zCbdnEpgQzbiNBa8dnYFmmQuOd741miCUwT0WNZmcmEvD_eEvlex6hd45-JlIHWIN4dq72qvMVQ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.186.98 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f2.1e100.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

halo_match
ids.ad.gt/api/v1/
43 B
651 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&halo_id=02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1elzfjf1hl5r1i1kkc2jl
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT
getpixels
pixels.ad.gt/api/v1/
0
344 B
Script
General
Full URL
https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&code=%27none%27
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
35.82.147.164 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-35-82-147-164.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

access-control-allow-origin
*
date
Tue, 21 Sep 2021 16:16:22 GMT
server
nginx/1.18.0
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
access-control-allow-methods
GET, POST, OPTIONS
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
ecommerce.js
www.google-analytics.com/plugins/ua/
1 KB
763 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ecommerce.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.142 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f14.1e100.net
Software
sffe /
Resource Hash
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 15:32:22 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
2640
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
738
x-xss-protection
0
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 21 Sep 2021 16:32:22 GMT
ec.js
www.google-analytics.com/plugins/ua/
3 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ec.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.142 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f14.1e100.net
Software
sffe /
Resource Hash
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 15:53:53 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1349
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1306
x-xss-protection
0
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Tue, 21 Sep 2021 16:53:53 GMT
openx
ids.ad.gt/api/v1/
Redirect Chain
  • https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3D02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8...
  • https://ids.ad.gt/api/v1/openx?openx_id=992d35b9-704a-495f-a47e-38fa4588a3d5&id=02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1e...
43 B
481 B
Image
General
Full URL
https://ids.ad.gt/api/v1/openx?openx_id=992d35b9-704a-495f-a47e-38fa4588a3d5&id=02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1elzfjf1hl5r1i1kkc2jl&auid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.10.191 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-10-191.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:22 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Wed, 22 Sep 2021 04:16:22 GMT

Redirect headers

date
Tue, 21 Sep 2021 16:16:22 GMT
content-encoding
gzip
server
OXGW/16.216.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
location
https://ids.ad.gt/api/v1/openx?openx_id=992d35b9-704a-495f-a47e-38fa4588a3d5&id=02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1elzfjf1hl5r1i1kkc2jl&auid=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
content-type
image/gif
alt-svc
clear
content-length
0
via
1.1 google
collect
www.google-analytics.com/j/
4 B
24 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j93&aip=1&a=985975207&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&dr=https%3A%2F%2Fgo.questexnetwork.com%2F&ul=en-us&de=UTF-8&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=aGDACEIZBAAAAC~&jid=102741857&gjid=913136774&cid=1519400072.1632240981&tid=UA-87198801-1&_gid=869232950.1632240981&_r=1&_slc=1&cd1=bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4&cd2=none&cd3=170&cd4=www.fiercepharma.com&cd5=%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients&cd6=Passive%20Tagger&cd7=e0fc5aa47bed062e265fc29d169e5770&z=1742185868
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.142 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f14.1e100.net
Software
Golfe2 /
Resource Hash
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
collect
stats.g.doubleclick.net/j/
4 B
25 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j93&tid=UA-87198801-1&cid=1519400072.1632240981&jid=102741857&gjid=913136774&_gid=869232950.1632240981&_u=aGDACEIZBAAAAC~&z=1397040582
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.251.5.156 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
wg-in-f156.1e100.net
Software
Golfe2 /
Resource Hash
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Tue, 21 Sep 2021 16:16:22 GMT
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.com/ads/
42 B
63 B
Image
General
Full URL
https://www.google.com/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j93&tid=UA-87198801-1&cid=1519400072.1632240981&jid=102741857&_u=aGDACEIZBAAAAC~&z=308034287
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.185.100 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s49-in-f4.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
ga-audiences
www.google.de/ads/
42 B
522 B
Image
General
Full URL
https://www.google.de/ads/ga-audiences?t=sr&aip=1&_r=4&slf_rd=1&v=1&_v=j93&tid=UA-87198801-1&cid=1519400072.1632240981&jid=102741857&_u=aGDACEIZBAAAAC~&z=308034287
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.186.99 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s06-in-f3.1e100.net
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
date
Tue, 21 Sep 2021 16:16:22 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, no-store, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-T051=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
multitracking
hb.mediafuse.com/adunit/
0
211 B
XHR
General
Full URL
https://hb.mediafuse.com/adunit/multitracking
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
23.227.137.155 Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 21 Sep 2021 16:16:21 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
index.php
a.dpmsrv.com/dpmpxl/
5 B
1 KB
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=xSeg&v=1.x&ep%5Bids%5D=16013439%2C16671093&cl=913&pixelIndex=0&r=285065&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&id=5735997925621329899&_=1632240981368
Requested by
Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.224.43.92 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-224-43-92.compute-1.amazonaws.com
Software
/
Resource Hash
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
31
Expires
0
seg
ib.adnxs.com/
43 B
1 KB
Image
General
Full URL
https://ib.adnxs.com/seg?member=%env(APPNEXUS_ID)&add=16013439,16671093
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.240 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
717.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

Pragma
no-cache
Date
Tue, 21 Sep 2021 16:16:23 GMT
X-Proxy-Origin
216.131.111.167; 216.131.111.167; 717.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
0d6fb8b1-b740-4eb7-b4df-97a24007e67a
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
publishertag.prebid.js
static.criteo.net/js/ld/
85 KB
27 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.130 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
e6969b69570c743952ab51b9fba22410be503db91b0566753d6da10894e76dad

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:23 GMT
content-encoding
gzip
last-modified
Wed, 08 Sep 2021 12:50:28 GMT
server
nginx
etag
W/"6138b194-1532d"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 22 Sep 2021 16:16:23 GMT
syncframe
gum.criteo.com/ Frame 09EA
11 KB
5 KB
Document
General
Full URL
https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fiercepharma.com
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
371f0ceab6655c8448f64525b1d11186cb67ca91398655ddf145c93d77964f91
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

:method
GET
:authority
gum.criteo.com
:scheme
https
:path
/syncframe?origin=publishertag&topUrl=www.fiercepharma.com
pragma
no-cache
cache-control
no-cache
upgrade-insecure-requests
1
user-agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
accept-language
de-DE,de;q=0.9
accept
text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site
cross-site
sec-fetch-mode
navigate
sec-fetch-dest
iframe
referer
https://www.fiercepharma.com/
accept-encoding
gzip, deflate, br
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

cache-control
private, max-age=3600
content-type
text/html; charset=utf-8
content-encoding
gzip
vary
Accept-Encoding
strict-transport-security
max-age=31536000
cross-origin-resource-policy
cross-origin
cross-origin-embedder-policy
require-corp
server-processing-duration-in-ticks
2087
set-cookie
uid=7ac0ad10-6a1d-4456-8807-70ec30939801; expires=Sun, 16 Oct 2022 16:16:23 GMT; domain=.criteo.com; path=/; secure; samesite=none
date
Tue, 21 Sep 2021 16:16:23 GMT
content-length
4664
publishertag.prebid.js
static.criteo.net/js/ld/
85 KB
27 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.130 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
e6969b69570c743952ab51b9fba22410be503db91b0566753d6da10894e76dad

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:23 GMT
content-encoding
gzip
last-modified
Wed, 08 Sep 2021 12:50:28 GMT
server
nginx
etag
W/"6138b194-1532d"
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Wed, 22 Sep 2021 16:16:23 GMT
json
gum.criteo.com/sid/ Frame 09EA
428 B
524 B
Fetch
General
Full URL
https://gum.criteo.com/sid/json?origin=publishertag&domain=fiercepharma.com&sn=ChromeSyncframe&so=3&topUrl=www.fiercepharma.com&bundle=Om99e18lMkZORWEydzNhMEJtNXI1Y0RRVWdnUVFRYk1pbURoVkZXMndjeWVRWmZwTlF0MXVEWUY2anRkNThFaHEwQTNSaWNjcWFidGFRaHlqYXo4YXlKWHdFd0dpRSUyRk9VWmFNZk45ZWhOMyUyQkxTOHElMkJ0S2Z3dU9zbEJLaENLZlJBUTgzcVlD&cw=1&lsw=1
Requested by
Host: gum.criteo.com
URL: https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fiercepharma.com
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
4f9cdd885c6363ca2017cbee03134032e62390ac15aa22b9395084c2fd3f734e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://gum.criteo.com/syncframe?origin=publishertag&topUrl=www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

pragma
no-cache
strict-transport-security
max-age=31536000
content-encoding
gzip
date
Tue, 21 Sep 2021 16:16:23 GMT
vary
Accept-Encoding
content-type
application/json; charset=utf-8
cache-control
no-cache, no-store, must-revalidate
server-processing-duration-in-ticks
2102
expires
0
v3_302826_6936.json
player.mediafuse.com/prebidlink/2720401/
27 KB
6 KB
XHR
General
Full URL
https://player.mediafuse.com/prebidlink/2720401/v3_302826_6936.json?cb=www.fiercepharma.com
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
213.174.135.2 Ashburn, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx/1.18.0 /
Resource Hash
331f512de6e73bb14b3ee53a16dbee02e92c9f0d28b7aef0196082d8b06ee140

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36

Response headers

date
Tue, 21 Sep 2021 16:16:24 GMT
content-encoding
gzip
last-modified
Tue, 21 Sep 2021 15:19:59 GMT
server
nginx/1.18.0
etag
W/"6149f81f-6d79"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
cache-control
max-age=3600
expires
Tue, 21 Sep 2021 17:16:24 GMT
692.json
id5-sync.com/g/v2/
213 B
538 B
XHR
General
Full URL
https://id5-sync.com/g/v2/692.json
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/453400/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
51.195.5.38 -, , ASN (),
Reverse DNS
Software
/
Resource Hash
62e515e793d62cea3472fcb312021349488253b1949e42ebe49f718c341d39a9
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/93.0.4577.63 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Tue, 21 Sep 2021 16:16:22 GMT
Access-Control-Allow-Credentials
true
Vary
Origin
Transfer-Encoding
chunked
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
Content-Type
application/json;charset=UTF-8

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
sync.teads.tv
URL
https://sync.teads.tv/um?eid=73&uid=230359ab-c1dc-4e63-a7cf-13805c1202b9-614a0555-5553&gdpr=0&gdpr_consent=
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/877?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&bcsessionid=&bctempid=&overruleReferrer=&time=2021-09-21T16%3A16%3A21%2B00%3A00&ts=1632240981465
Domain
app-sj10.marketo.com
URL
https://app-sj10.marketo.com/index.php/form/XDFrame
Domain
inv-nets.admixer.net
URL
https://inv-nets.admixer.net/prebid.1.1.aspx?data={%22imps%22:[{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%2245af0858e1f742e0b8d3eb59c8497dcf%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303291,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[970,250]]}},%22adUnitCode%22:%22header-ad%22,%22transactionId%22:%22dc6dfb20-ade5-4e29-81c2-775c8b0961dd%22,%22sizes%22:[[970,250]],%22bidId%22:%2217923a750a8783bf%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%22d0899d2dba60442f94ce093cf48e46d7%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303292,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[970,90]]}},%22adUnitCode%22:%22header-ad%22,%22transactionId%22:%22dc6dfb20-ade5-4e29-81c2-775c8b0961dd%22,%22sizes%22:[[970,90]],%22bidId%22:%2218054cd3c95d8704%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad%22,%22transactionId%22:%221e8800a0-50d8-48df-b1d6-aa9a5093a84a%22,%22sizes%22:[[300,250]],%22bidId%22:%22181289d32bfeeca4%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad%22,%22transactionId%22:%221e8800a0-50d8-48df-b1d6-aa9a5093a84a%22,%22sizes%22:[[300,600]],%22bidId%22:%22182d280c95da1f2a%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad2%22,%22transactionId%22:%22ddcdc59f-da31-4ac7-981e-974923cbf150%22,%22sizes%22:[[300,250]],%22bidId%22:%221833da2758f7fe6a%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad2%22,%22transactionId%22:%22ddcdc59f-da31-4ac7-981e-974923cbf150%22,%22sizes%22:[[300,600]],%22bidId%22:%221848aa49ccb0caf%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad3%22,%22transactionId%22:%2260c6d7d6-e225-48da-bc22-5d29a93d3726%22,%22sizes%22:[[300,250]],%22bidId%22:%22185d1527ccca99c5%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad3%22,%22transactionId%22:%2260c6d7d6-e225-48da-bc22-5d29a93d3726%22,%22sizes%22:[[300,600]],%22bidId%22:%22186b6e469da25482%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0}],%22referrer%22:%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%22}
Domain
4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com
URL
https://4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221632240981094%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981096%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981097%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221632240981098%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&bcsessionid=&bctempid=&overruleReferrer=&time=2021-09-21T16%3A16%3A21%2B00%3A00&callback=bc_json879
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221632240981094%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981096%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981097%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221632240981098%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&bcsessionid=&bctempid=&overruleReferrer=&time=2021-09-21T16%3A16%3A21%2B00%3A00&callback=bc_json880
Domain
ads.spotible.com
URL
https://ads.spotible.com/tag/universal-tag.js

Verdicts & Comments Add Verdict or Comment

132 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| event object| onbeforexrselect boolean| originAgentCluster object| NREUM object| newrelic function| __nr_require function| mobileCheck object| dataLayerValues object| dataLayer object| googletag object| vmpbjs object| vpb object| a2a_config object| Modernizr object| blueConicPreListeners function| BCClass object| blueConicClient string| ssaUrl undefined| $ function| jQuery object| drupalSettings object| Drupal object| picturefillCFG function| picturefill function| _toConsumableArray function| disablePurgingButton function| vmpbjsChunk object| _pbjsGlobals object| mnet string| nobidVersion object| nobid object| a2a function| a2a_show_dropdown function| a2a_miniLeaveDelay function| a2a_init string| min_a2a string| min_1 string| min_2 string| min_3 string| min_4 string| min_5 string| min_6 string| min_7 string| min_8 string| min_9 string| min_10 string| min_11 number| a2apage_init object| icons string| svg_tag_open string| svg_tag_close undefined| svg_src undefined| svg_src_default object| MktoForms2 function| mktoFormSubmitCallback object| WebFont object| google_tag_manager object| PARSELY object| ggeac object| google_js_reporting_queue object| google_tag_data string| GoogleAnalyticsObject function| ga string| method string| bid string| oid object| olytics object| a string| qtxSection object| _ml function| readCookie function| profileIdExecute string| queryString boolean| disableBcMarketoIntegration undefined| color function| _typeof function| Dpxl object| dpmPixels object| jQuery111107660269811263696 boolean| CE_USER_SCRIPT object| CE2 string| CE_USER_DATA_URL object| gaplugins object| gaGlobal object| gaData object| jQuery112405524613783905166 function| Goog_AdSense_getAdAdapterInstance function| Goog_AdSense_OsdAdapter undefined| google_measure_js_timing string| CE_USER_COMMON_SCRIPT_URL string| CE_USER_THIRDPARTY_SCRIPT_URL object| bc_json878 object| CE2BH object| Criteo object| googleToken object| googleIMState function| processGoogleToken number| __google_ad_urls_id number| google_unique_id function| bc_json879 function| __$PP function| bc_json880 boolean| inDapIF boolean| inGptIF object| ids object| prontoTag object| scriptTag object| prontoTags object| __google_ad_urls boolean| google_osd_loaded boolean| google_onload_fired function| Goog_Osd_UnloadAdBlock function| Goog_Osd_UpdateElementToMeasure function| google_osd_amcb object| GoogleGcLKhOms object| auvars function| mktoMunchkinFunction object| Munchkin function| mktoMunchkin object| google_image_requests object| au function| docReady object| autag function| setImmediate function| clearImmediate object| criteo_pubtag object| criteo_pubtag_prebid_113 object| Criteo_prebid_113

101 Cookies

Domain/Path Name / Value
www.fiercepharma.com/pharma Name: hasLiveRampMatch
Value: true
go.questexnetwork.com/ Name: BIGipServersj_mailtracking_http
Value: !8PiIn8guBIEFCsMlU8cyx3LfarvBcWtukrW2b3Xv3uZI6kqkClzclfaH4h/MiHC9Ymc7ta2CeRIVYPI=
.go.questexnetwork.com/ Name: __cf_bm
Value: 5hJNTr7gWWxaLKgN6zCnylKmTUjmAXeiJ_Jor2vNLxw-1632240979-0-AeAZDhvCtB1i9SV5TiNLGsDtp7/SUXR6NyKYQruCrNE0kRU497rAh+kt+p56tPLLK3xvL3D8BuiHlSyP280VCSg=
www.fiercepharma.com/ Name: last_visit_bc
Value: 1632240981091
.app-sj10.marketo.com/ Name: __cf_bm
Value: AyNz_uwCDzQJBjG2AJCeg1aMl0yWOK9wZP1x8Cn5pxU-1632240981-0-AX53FRGm+7eD/GCN/ZJlt0VDSlSf+UcV63Gjsl+74nzHJVvj0vbksaY3jqtfnELZZ6y6WAE0G+4PzTAtEZKBL+M=
.sitescout.com/ Name: ssi
Value: 230359ab-c1dc-4e63-a7cf-13805c1202b9#1632240981258
.sitescout.com/ Name: _ssuma
Value: eyIzNCI6MTYzMjI0MDk4MTI4MiwiMiI6MTYzMjI0MDk4MTI4MiwiNCI6MTYzMjI0MDk4MTI4MiwiMzkiOjE2MzIyNDA5ODEyODIsIjciOjE2MzIyNDA5ODEyODJ9
.fiercepharma.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038%22%2C%22sref%22:%22https://go.questexnetwork.com/%22%2C%22sts%22:1632240981344%2C%22slts%22:0}
.fiercepharma.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=fc42f22474ff7de5cd35fe5ce0826f95%22%2C%22session_count%22:1%2C%22last_session_ts%22:1632240981344}
www.fiercepharma.com/ Name: dpm_url_count
Value: 1
questex.blueconic.net/ Name: AWSALBCORS
Value: VmGEk0Yd7AFXCkEcFrJ2+T3g3ks0YegzfYmhVwW+8/8BdRyNhqL/vlGroJ6MutM7BlNydNzZZB7uGSkiy/n8TF6epcxR5jx64RgIZIItO+WQxTodpy5snmjMM+P8
.fiercepharma.com/ Name: _ga
Value: GA1.2.1519400072.1632240981
.fiercepharma.com/ Name: _gid
Value: GA1.2.869232950.1632240981
.adnxs.com/ Name: uuid2
Value: 5735997925621329899
.fiercepharma.com/ Name: _gat_UA-336524-28
Value: 1
.tapad.com/ Name: TapAd_TS
Value: 1632240981408
.tapad.com/ Name: TapAd_DID
Value: f30f8678-91da-4c86-8b24-ad5b2687a289
.demdex.net/ Name: demdex
Value: 19663782927819267720830632050847266550
.tapad.com/ Name: TapAd_3WAY_SYNCS
Value:
www.fiercepharma.com/ Name: _pbjs_userid_consent_data
Value: 3524755945110770
.fiercepharma.com/ Name: _pubcid
Value: 63c11385-5041-4954-ad53-e44236d05f2c
.dpm.demdex.net/ Name: dpm
Value: 19663782927819267720830632050847266550
.crwdcntrl.net/ Name: _cc_dc
Value: 1
.crwdcntrl.net/ Name: _cc_id
Value: e9280626cc39bdf9e8c80f64088043de
.crwdcntrl.net/ Name: _cc_cc
Value: "ACZ4XmNQSLU0sjAwMzJLTja2TEpJs0y1SLYwSDMzMbCwMDAxTkllAIJEL9ZQEA0FAEeRCcs%3D"
.crwdcntrl.net/ Name: _cc_aud
Value: "ABR4XmNgYGBI9GINBVJQAAANBQEG"
.mediafuse.com/ Name: vmuid
Value: 6c19bbbd5f59ccf6
.ws.zoominfo.com/ Name: visitorId
Value: c96ea9e237b8540d1e96b7af0b1ecc48eea7512f17befe224b499d17292e7838
.zoominfo.com/ Name: __cf_bm
Value: Uy0DIlwCKPXOrvfRKPjXw5ifQB33U1gYOkgzx.EBgcM-1632240981-0-AVnzTu7fW5M2jCI6WVRH2uYotaf6Vm1YnDPHq+FcWRANsNTb9x1QqosBsdUUd5Gp8iab5sBy60vDWthg6TLy4NA=
www.fiercepharma.com/ Name: cto_bidid
Value: ZpSkYV9Xb3NaOWpqWkFLTXRDOVpWZG5pNnNKT0xERjFsNkhub0lYb3gyWVptYTBLWXc4ZlUlMkJCWXNVN09NazdYQUhZbE9reE0wbjg3NklOMllwWCUyQm94V1Q0cHclM0QlM0Q
www.fiercepharma.com/ Name: cto_bundle
Value: Om99e18lMkZORWEydzNhMEJtNXI1Y0RRVWdnUVFRYk1pbURoVkZXMndjeWVRWmZwTlF0MXVEWUY2anRkNThFaHEwQTNSaWNjcWFidGFRaHlqYXo4YXlKWHdFd0dpRSUyRk9VWmFNZk45ZWhOMyUyQkxTOHElMkJ0S2Z3dU9zbEJLaENLZlJBUTgzcVlD
.lijit.com/ Name: ljtrtb
Value: eJyrrgUAAXUA%2BQ%3D%3D
.openx.net/ Name: i
Value: 63c11385-5041-4954-ad53-e44236d05f2c|1632240981
.go.sonobi.com/ Name: __uis
Value: 39227249-44c9-4e14-81e2-3aebc2a43cad
.go.sonobi.com/ Name: _usd_fiercepharma.com
Value: 4c8a2973-ea95-4b92-8d4b-e769c19a6739
.go.sonobi.com/ Name: __uir_td
Value: 1
.go.sonobi.com/ Name: __uir_bw
Value: 1
.go.sonobi.com/ Name: __uir_mm
Value: 1
.go.sonobi.com/ Name: __uir_pp
Value: 1
.go.sonobi.com/ Name: __uir_zt
Value: 1
.go.sonobi.com/ Name: __uin_bp
Value: 1
.go.sonobi.com/ Name: __uir_bp
Value: 1
.go.sonobi.com/ Name: __uir_eb
Value: 1
.go.sonobi.com/ Name: __uir_rx
Value: 1
.go.sonobi.com/ Name: __uir_so
Value: 1
.go.sonobi.com/ Name: HAPLB5A
Value: s5610|YUoFW
.rubiconproject.com/ Name: rsid
Value: 1|HsGqLFsFr/vVSy6g0MQzNQWiuYBcZJvAvCF6IsCkVVYgwYaQOmrhQqqdY7qJ5+fKRB+v2jLGFGeoFyjBXEn+RTT+pWw62G0J5h4qb83eS0hKp2u2D6IxNbX7Tc/cWQrERdSf+hE=
.rubiconproject.com/ Name: ses15
Value:
.rubiconproject.com/ Name: vis15
Value: 163630^1
.rubiconproject.com/ Name: khaos
Value: KTUA4XWD-22-KN1M
.rubiconproject.com/ Name: ses55
Value:
.rubiconproject.com/ Name: vis55
Value: 163630^1
.rubiconproject.com/ Name: audit
Value: 1|naVuGyos1qq5rjN/3YUlWubG3qYILEpY8Vdw+9gcgdU0T9qdPU+bd4aOg68LOvB6LgC5hdm/4WZo2B05UvZjL0ZjA/ErGVhBsqlSNZOaaDQ=
.ad.gt/ Name: au_id
Value: bf33c0c1-7e0e-4718-a6c3-7cd134dbadb4
.ad.gt/ Name: au_idmatch
Value: {"apn": "2021-09-21", "ttd": "2021-09-21", "pub": "2021-09-21", "adx": "2021-09-21", "halo": "2021-09-21", "goo": "2021-09-21", "taboola": "2021-09-21", "son": "2021-09-21", "ado": "2021-09-21"}
.betweendigital.com/ Name: dc
Value: was1
.betweendigital.com/ Name: tuuid
Value: e12121f3-3b49-5308-b569-d959d423dc0c
.betweendigital.com/ Name: ut
Value: YUoFVQAMLTAKw8z_xxwgN5-mw0vqrD7EF7luyw==
.betweendigital.com/ Name: ss
Value: 1
.betweendigital.com/ Name: unm
Value: 1
.dpmsrv.com/ Name: dpm_pxl
Value: e3437adccbb17bbd04966c350d45f7a16afb9eb3
.dpmsrv.com/ Name: dpm_pxl_aid
Value: 5735997925621329899
.adtelligent.com/ Name: vmuid
Value: 81a1960d96ec7b55
.pubmatic.com/ Name: KTPCACOOKIE
Value: true
.pubmatic.com/ Name: KADUSERCOOKIE
Value: D669AC34-AAD1-4434-8683-EE81A74C2B93
.adsrvr.org/ Name: TDID
Value: 010e5372-0935-48b5-85bd-1e6e2626ad58
.adsrvr.org/ Name: TDCPM
Value: CAEYBSABKAIyCwi28uGfvMn-ORAFOAE.
.doubleclick.net/ Name: IDE
Value: AHWqTUlQdSbUNMIrIf5sbE_0UAUu2SlnjgzjhEYgTa2kMLoPYSWsPm0iUYEPBNJY0hs
.fiercepharma.com/ Name: __gads
Value: ID=bf0e63c8d45b7c74:T=1632240981:S=ALNI_MbYdedNR4PRISCHwPzhTVFj5kywyA
.adtelligent.com/ Name: a319130
Value: bb66e291-b090-42ef-9d5e-99e0a0cdd854
.ad.gt/ Name: last_seeng_hosted
Value: 1632240982285
.ad.gt/ Name: g_hosted
Value:
.ad.gt/ Name: last_seenson
Value: 1632240982297
.ad.gt/ Name: uid
Value: 39227249-44c9-4e14-81e2-3aebc2a43cad
.ad.gt/ Name: last_seenadnxs
Value: 1632240982300
.ad.gt/ Name: adnxs_id
Value: 5735997925621329899
.ad.gt/ Name: first_seenadnxs
Value: 1632240982300
.ad.gt/ Name: last_seenadx
Value: 1632240982299
.ad.gt/ Name: google_gid
Value: CAESEGI2Rf67IBhFIcjr05CHMLg
.ad.gt/ Name: first_seenadx
Value: 1632240982299
.fiercepharma.com/ Name: _gat_auPassiveTagger
Value: 1
.ad.gt/ Name: last_seentd
Value: 1632240982304
.ad.gt/ Name: tdid
Value: 010e5372-0935-48b5-85bd-1e6e2626ad58
.ad.gt/ Name: first_seentd
Value: 1632240982304
.ad.gt/ Name: last_seenpbm
Value: 1632240982303
.ad.gt/ Name: pbm
Value: D669AC34-AAD1-4434-8683-EE81A74C2B93
.ad.gt/ Name: first_seenpbm
Value: 1632240982303
.ad.gt/ Name: last_seenhaloid
Value: 1632240982457
.ad.gt/ Name: halo_id
Value: 02000hc5ci07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj91nelrdq1elzfjf1hl5r1i1kkc2jl
.ad.gt/ Name: first_seenhaloid
Value: 1632240982457
.ad.gt/ Name: last_seenadb
Value: 1632240982458
.ad.gt/ Name: adb
Value: 19663782927819267720830632050847266550
.ad.gt/ Name: last_seenopenx
Value: 1632240982517
.ad.gt/ Name: openx_id
Value: 992d35b9-704a-495f-a47e-38fa4588a3d5
www.fiercepharma.com/ Name: dpm_time_site
Value: 2.009
.adnxs.com/ Name: anj
Value: dTM7k!M4/8CxrEQF']wIg2GU(qDl_P!]tbP6j2F-XstGt!@D?F$WrGC
.dpmsrv.com/ Name: xdpm_segsid_913
Value: 16013439%2C16671093
.dpmsrv.com/ Name: xdpm_segs_913
Value:
.criteo.com/ Name: uid
Value: 7ac0ad10-6a1d-4456-8807-70ec30939801
.fiercepharma.com/ Name: cto_bundle
Value: u0bh718lMkZORWEydzNhMEJtNXI1Y0RRVWdnUWVYdG1TeVZiQjElMkZtY25kOEVRcm9xdUdEamZzVmJQend2c3JPQmRITW1Fc0pJNUw5Tm5RZ3ZzRHhDVVZWQk9hYlJNalM5RFVvWkN2b3BuSEtVRGlDb0lqenRnMmYlMkZkWkVZVVdObndpcG9Iek80OVI5SEhRMkQ2emgyQlBCY2UzRkElM0QlM0Q
.www.fiercepharma.com/ Name: cto_bundle
Value: u0bh718lMkZORWEydzNhMEJtNXI1Y0RRVWdnUWVYdG1TeVZiQjElMkZtY25kOEVRcm9xdUdEamZzVmJQend2c3JPQmRITW1Fc0pJNUw5Tm5RZ3ZzRHhDVVZWQk9hYlJNalM5RFVvWkN2b3BuSEtVRGlDb0lqenRnMmYlMkZkWkVZVVdObndpcG9Iek80OVI5SEhRMkQ2emgyQlBCY2UzRkElM0QlM0Q

6 Console Messages

Source Level URL
Text
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/877?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&bcsessionid=&bctempid=&overruleReferrer=&time=2021-09-21T16%3A16%3A21%2B00%3A00&ts=1632240981465
Message:
Failed to load resource: net::ERR_NAME_NOT_RESOLVED
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221632240981094%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981096%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981097%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221632240981098%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&bcsessionid=&bctempid=&overruleReferrer=&time=2021-09-21T16%3A16%3A21%2B00%3A00&callback=bc_json879
Message:
Failed to load resource: net::ERR_NAME_NOT_RESOLVED
javascript error URL: https://www.fiercepharma.com/pharma/more-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients?mkt_tok=Mjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI&mrkid=170732038
Message:
Access to XMLHttpRequest at 'https://inv-nets.admixer.net/prebid.1.1.aspx?data={%22imps%22:[{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%2245af0858e1f742e0b8d3eb59c8497dcf%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303291,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[970,250]]}},%22adUnitCode%22:%22header-ad%22,%22transactionId%22:%22dc6dfb20-ade5-4e29-81c2-775c8b0961dd%22,%22sizes%22:[[970,250]],%22bidId%22:%2217923a750a8783bf%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%22d0899d2dba60442f94ce093cf48e46d7%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303292,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[970,90]]}},%22adUnitCode%22:%22header-ad%22,%22transactionId%22:%22dc6dfb20-ade5-4e29-81c2-775c8b0961dd%22,%22sizes%22:[[970,90]],%22bidId%22:%2218054cd3c95d8704%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad%22,%22transactionId%22:%221e8800a0-50d8-48df-b1d6-aa9a5093a84a%22,%22sizes%22:[[300,250]],%22bidId%22:%22181289d32bfeeca4%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad%22,%22transactionId%22:%221e8800a0-50d8-48df-b1d6-aa9a5093a84a%22,%22sizes%22:[[300,600]],%22bidId%22:%22182d280c95da1f2a%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad2%22,%22transactionId%22:%22ddcdc59f-da31-4ac7-981e-974923cbf150%22,%22sizes%22:[[300,250]],%22bidId%22:%221833da2758f7fe6a%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad2%22,%22transactionId%22:%22ddcdc59f-da31-4ac7-981e-974923cbf150%22,%22sizes%22:[[300,600]],%22bidId%22:%221848aa49ccb0caf%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad3%22,%22transactionId%22:%2260c6d7d6-e225-48da-bc22-5d29a93d3726%22,%22sizes%22:[[300,250]],%22bidId%22:%22185d1527ccca99c5%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad3%22,%22transactionId%22:%2260c6d7d6-e225-48da-bc22-5d29a93d3726%22,%22sizes%22:[[300,600]],%22bidId%22:%22186b6e469da25482%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0}],%22referrer%22:%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%22}' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://inv-nets.admixer.net/prebid.1.1.aspx?data={%22imps%22:[{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%2245af0858e1f742e0b8d3eb59c8497dcf%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303291,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[970,250]]}},%22adUnitCode%22:%22header-ad%22,%22transactionId%22:%22dc6dfb20-ade5-4e29-81c2-775c8b0961dd%22,%22sizes%22:[[970,250]],%22bidId%22:%2217923a750a8783bf%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%22d0899d2dba60442f94ce093cf48e46d7%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303292,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[970,90]]}},%22adUnitCode%22:%22header-ad%22,%22transactionId%22:%22dc6dfb20-ade5-4e29-81c2-775c8b0961dd%22,%22sizes%22:[[970,90]],%22bidId%22:%2218054cd3c95d8704%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad%22,%22transactionId%22:%221e8800a0-50d8-48df-b1d6-aa9a5093a84a%22,%22sizes%22:[[300,250]],%22bidId%22:%22181289d32bfeeca4%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad%22,%22transactionId%22:%221e8800a0-50d8-48df-b1d6-aa9a5093a84a%22,%22sizes%22:[[300,600]],%22bidId%22:%22182d280c95da1f2a%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad2%22,%22transactionId%22:%22ddcdc59f-da31-4ac7-981e-974923cbf150%22,%22sizes%22:[[300,250]],%22bidId%22:%221833da2758f7fe6a%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad2%22,%22transactionId%22:%22ddcdc59f-da31-4ac7-981e-974923cbf150%22,%22sizes%22:[[300,600]],%22bidId%22:%221848aa49ccb0caf%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%221166104b202a4a958275513fadae1285%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303287,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,250]]}},%22adUnitCode%22:%22sidebar-ad3%22,%22transactionId%22:%2260c6d7d6-e225-48da-bc22-5d29a93d3726%22,%22sizes%22:[[300,250]],%22bidId%22:%22185d1527ccca99c5%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0},{%22id%22:7633,%22name%22:%22Admixer%22,%22adapter_id%22:779,%22type%22:%22display%22,%22bidder%22:%22admixer_mkp%22,%22entityId%22:16893,%22geo%22:{%22type%22:%22block%22,%22list%22:{},%22skipGeo%22:true},%22isMarket%22:true,%22params%22:{%22zone%22:%228327cd6ee4004d18ab068dc892e702ae%22},%22minViewWithDfp%22:0,%22noR%22:0,%22geoEdgeIndex%22:0,%22overrideId%22:2303288,%22labels%22:[],%22validLabelIds%22:[],%22userId%22:{%22pubcid%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22},%22userIdAsEids%22:[{%22source%22:%22pubcid.org%22,%22uids%22:[{%22id%22:%2263c11385-5041-4954-ad53-e44236d05f2c%22,%22atype%22:1}]}],%22mediaTypes%22:{%22banner%22:{%22sizes%22:[[300,600]]}},%22adUnitCode%22:%22sidebar-ad3%22,%22transactionId%22:%2260c6d7d6-e225-48da-bc22-5d29a93d3726%22,%22sizes%22:[[300,600]],%22bidId%22:%22186b6e469da25482%22,%22bidderRequestId%22:%221783d865b07b4c44%22,%22auctionId%22:%22ua4xrt.37%22,%22src%22:%22client%22,%22bidRequestsCount%22:1,%22bidderRequestsCount%22:2,%22bidderWinsCount%22:0}],%22referrer%22:%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%22}
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221632240981094%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038%5C%22%5D%2C%5C%22referrerhost%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%2C%5C%22referrerhost%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981096%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22referrerhosts%5C%22%3A%5B%5C%22go.questexnetwork.com%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%2C%5C%22referrerhosts%5C%22%5D%7D%7D%22%2C%22id%22%3A%221632240981097%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22https%3A%2F%2Fgo.questexnetwork.com%2F%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221632240981098%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fmore-evidence-emerges-ineffectiveness-gilead-s-veklury-covid-19-patients%3Fmkt_tok%3DMjk0LU1RRi0wNTYAAAF_lJnukLaF183CeXqj4VDV0jweluaOfX-GcXjHKvsRBFanawVk_5CKbObF0x06bdVESSIdUE4AXC_jJ6ZyeoITPm_82Lv1UJTQmRE8FbSKCUmeSwoBmvI%26mrkid%3D170732038&bcsessionid=&bctempid=&overruleReferrer=&time=2021-09-21T16%3A16%3A21%2B00%3A00&callback=bc_json880
Message:
Failed to load resource: net::ERR_NAME_NOT_RESOLVED
network error URL: https://idsync.rlcdn.com/423396.gif?partner_uid=5735997925621329899
Message:
Failed to load resource: the server responded with a status of 451 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Content-Type-Options nosniff

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com
a.ad.gt
a.dpmsrv.com
ads.betweendigital.com
ads.servenobid.com
ads.spotible.com
ads.us.e-planning.net
adservice.google.com
adservice.google.de
adtelligent-d.openx.net
ajax.googleapis.com
ap.lijit.com
apex.go.sonobi.com
api-34-211-87-144.b2c.com
api.fouanalytics.com
app-sj10.marketo.com
aufp.io
bcp.crwdcntrl.net
bidder.criteo.com
c2shb.ssp.yahoo.com
c405.fiercepharma.com
cdn.blueconic.net
cdn.parsely.com
cm.g.doubleclick.net
colossusssp.com
csync.loopme.me
d1z2jf7jlzjs58.cloudfront.net
dm.hybrid.ai
dpm.demdex.net
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
ghb.adtelligent.com
go.questexnetwork.com
gum.criteo.com
hb.mediafuse.com
hbopenbid.pubmatic.com
ib.adnxs.com
id5-sync.com
ids.ad.gt
idsync.rlcdn.com
image2.pubmatic.com
in.ml314.com
inv-nets.admixer.net
loadm.exelator.com
match.adsrvr.org
maxcdn.bootstrapcdn.com
ml314.com
munchkin.marketo.net
olytics.omeda.com
onetag-sys.com
p.ad.gt
p1.parsely.com
pagead2.googlesyndication.com
pixel-a.basis.net
pixel.sitescout.com
pixel.tapad.com
pixels.ad.gt
player.adtelligent.com
player.mediafuse.com
prebid-us.creativecdn.com
prebid.a-mo.net
prebid.adnxs.com
prebid.media.net
qtxasset.com
questex.blueconic.net
rtb.adxpremium.services
s.dpmsrv.com
script.crazyegg.com
secure.adnxs.com
securepubads.g.doubleclick.net
static.addtoany.com
static.criteo.net
stats.g.doubleclick.net
sync.adtelligent.com
sync.go.sonobi.com
sync.medidexs.com
sync.teads.tv
t.trafmag.com
tag.1rx.io
tpc.googlesyndication.com
tracking.crazyegg.com
trc.taboola.com
u.openx.net
ws.zoominfo.com
www.fiercepharma.com
www.google-analytics.com
www.google.com
www.google.de
www.googletagmanager.com
www.googletagservices.com
4409e52c47aceeec7cfa21e138390bc4.safeframe.googlesyndication.com
ads.spotible.com
app-sj10.marketo.com
c405.fiercepharma.com
inv-nets.admixer.net
sync.teads.tv
104.16.168.82
104.16.92.165
104.16.92.80
104.18.10.207
104.18.15.141
104.19.148.8
104.21.75.33
104.26.7.35
13.224.193.55
13.224.193.97
13.224.194.156
13.225.85.39
13.248.242.197
135.125.163.79
142.250.181.225
142.250.184.202
142.250.185.100
142.250.185.142
142.250.185.194
142.250.185.226
142.250.186.170
142.250.186.34
142.250.186.66
142.250.186.98
142.250.186.99
142.250.74.195
142.251.5.156
147.75.38.124
151.101.193.44
162.55.6.211
172.217.16.136
172.217.23.98
172.67.200.52
172.67.39.148
178.162.133.149
178.162.133.150
178.250.2.130
178.250.2.131
178.250.2.146
185.184.10.30
185.239.173.66
185.33.220.240
185.33.221.89
185.64.189.110
185.64.189.112
193.200.65.5
204.180.130.159
213.174.135.1
213.174.135.2
213.19.147.43
213.19.162.61
216.52.2.19
23.227.137.155
23.66.157.159
3.224.43.92
3.226.134.17
3.234.170.180
34.107.148.139
34.223.151.79
34.253.109.165
34.254.143.3
35.163.47.212
35.227.248.159
35.244.159.8
35.244.174.68
35.82.147.164
37.18.16.23
37.252.161.190
46.249.52.248
51.195.5.38
51.89.9.251
52.205.167.202
52.208.138.90
52.25.225.148
52.28.203.152
52.35.10.191
54.171.219.200
54.228.75.94
54.73.172.176
62.149.0.72
66.155.71.149
88.214.207.207
96.46.186.57
026c5db877da222d2316bf1197b8947a96c7623d51a4d462c91bf927dece3429
02c6f00a6532bdaf7cfe366bd198cd2d2ab2e9da0aa6f2a9f263db752f00ff6b
0343964aa4a32ab4c3754c8e7387dc859d2dd70292493ff2b88aa707f037d311
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
05eede14d1b0df231630154638b6c445f95086558dc2d021db08e4e1a2c201cd
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
0c09c070833c786cb25be38bc30992b30bad578f817dbc9e34beacd8b8ea44c5
0d9762a1a60deef8aa093c473ad27c38eed77184d6940e7df06d89d77cbd3e94
14c8c62dc692fd8faa04434e3fed25e7c23d596b732f9db88f6e9f9ff5dfa61c
1882996e48b3b800108df06670df431af4a6f9b18eb54f4a74c0d601af52c641
18dda3fa8bd592f1e8f20307acb49711ce0a723d28fc3e740538cd4a144fed4b
19d8552b92ae03e066893a9d818a5336bd0d107812dff3c05daef636d8750d38
19e011d9a556628501b1557416b8af87442f7baf56cd957a1561d3075c6404c7
1b05ce33469db78a252caf0e176e3cb56cd4d1d17aa3c3cda89f8088bb3eefda
1cc9e0ac0ff231ba3fc0c9c42b40ebcc6c5a3058722ca99eeb0fed41f3efb997
1daf67a5a85e55210b5e212a8be8392f1f93c01ce54effd63eab78f0b80dfb44
1e85ec81b9800b4c443d39caca0d0926089a3ac201120db1ceb45b93789480b8
20cabe8c26414d50bb327e2d2beb3d5086765f8b24191cb9a617cc0b19216064
256e42104f48a5fa80b031da12dc56acde224fba3f9810f8f8192b39136d365a
2689a0237a95cfd8135f8da3ac79c430e903f3c542f8b862f68141c84c348c43
281b85571f7f21480cd64551cffd1f6daf7613b9fee4c21b520d92f3bd52661c
28a90aadb5c22faff135da00584afd9b830dded1067dc454612e986db6b7a9db
2ad9341e45c5e7676ed8925d391b5a96802a29c898d1e4909c4537c0f5a6a2ce
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363
2e198425d0be101ff0adca902573d7a19a79c857d29a5f80a85e432b517a04d4
2e57534a870998d111229d916714b55593b33025ad464840d3b8b6025f8f96ba
2f561b02a49376e3679acd5975e3790abdff09ecbadfa1e1858c7ba26e3ffcef
2fbc870d58a2b1e76dfa9c7a5e8e5b21a46a1f62940bae52931acaf3d1e2ef4b
320147ea3a4898ab2d77393d503ba7416b9ef6e5eee4351d6506458adb92ae5a
331f512de6e73bb14b3ee53a16dbee02e92c9f0d28b7aef0196082d8b06ee140
336a2c6b0eaf929e5c5be1659be540dcc2cd6df5cc2971ecf4d65480f7505609
371f0ceab6655c8448f64525b1d11186cb67ca91398655ddf145c93d77964f91
3909f3fca633cdc857cbbbf9fe3af90e3e51039e748ff57ec216487b91da304b
3eb10792d1f0c7e07e7248273540f1952d9a5a2996f4b5df70ab026cd9f05517
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a
464db77e594c4a27c0045999f846985c69658f13688c9fa49e87baf3ca3e96b2
4ac59813960cff57e86e77a2d0572b41db5f20cefa7758749f33da3625fd9565
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
4df74cfc86e566c05ff7f65e2ff5139aa6d03637da6d084c5d43131041e0218c
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945
4f9cdd885c6363ca2017cbee03134032e62390ac15aa22b9395084c2fd3f734e
4fa0156d693856f79289525c8e4db988a188d55ce0283351c96d811c7ce3e2c3
4fcc6ead9577d358d15d1777368453472824acea19b0c5f2fabd7dfbdd326dd9
574dfdea32af395d12ab993e5c174666977ee0cbdcecf3431ec4337db3aa685e
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1
5baa1f22b8a6567727c2c9fe473d214051daf6a86f7d9347d30b0093ab22f09d
5f18dc38e84dbadb36b6e7d6da27e45e6fdf4c41ddac6a53452503922e96a73a
62e515e793d62cea3472fcb312021349488253b1949e42ebe49f718c341d39a9
62f586be8571b23584eb4a60a45a3157ff7c8388b1b1e3b4e8890e243b3e47de
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
680030a41d9b8dcd5edc79e159a420da353dd6638a041a6db69eb0df8b5073b2
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
729f27962e75f860eab46d9853fc8a49cfb771349f0cc07defe7da908a0092dc
72c561fa658c163b0d597cc2eadd3cedca62712ef8aab4d7a1dcff790e60fa94
72e2d9163b9e20de589651265ccca67a06a0da9669460eefa0a2beb354d0c18c
7533826884f96d6479ad16c923fb9ad6d9dad65930f9e3a4a5c82ebcdfd92f5c
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
79eb377ce6bceb76026a970e704b7aa754f7290a757e7b07b8d2e877afe69c2f
81016ac6be850b72df5d4faa0c3cec8e2c1b0ba0045712144a6766adfad40bee
8111f22e56354c8880315afdd87fe63c7d82284596f7288969247a118accc642
832d8d5a3cabdde474e79d8a510053604d5d19342befbc7b78dc64995652dbba
84e01419bd81f32ac6df0f75f49c604fda9172000a3ae432b3c47b2a6a712d80
85e50082d7ce113bfa87dbade18dbf747d1bacfcffdbd628296dcffa98a08f94
88944d76219bb324ba3d28ac3981cf303569dd397d2ba6848fc67789c07728ad
8ba1802771d9ea1b704d1179b94051e114edacf81bafbfa559c6a50dbe013ecd
8ce726b04c9b2ab27be0f6b238c8f3c4c7678781c3921daed4266b4ccf218a6f
8d827f9f5d362e46cbfb604b80439d48ada61dc5670d8dc139f367b13c139e3b
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
9b17ed6f201a539d617120eb2b829a3a32a661daf2f04893c5978b25dd781034
a2196b2080c19dcf3bb0aae9dc76ad19c205ef5512e75e0580028f023e1222fa
a4702a77ebe38f4291b9ec9f44411e246c865bdf0070746852e803b4d960fc1c
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
a5ead9037af4a0e749e217f63b25a25493a7705e17d98f04b336ab1370a353db
a61ad9d1915814d7822ac27ef8d1e98af9dac45f44297dee24bd0a30bd0b526f
a6942ecf4f00c9c0386d1fd509050be4a4f4247f2d214313e17ad127b027e564
a6c924fc03e24568ae4d53734da38aabcf7d99aec660c568c6502e37774f5d04
a7cc862fa321079663a10c74016fb86ed81e9ffbb76b3b0a80ec462e8264f112
ab979f0abc8b8119d48362ec7d18e8b613ec677f99cc76d8d10c6b9a76be7ad8
ac0b0f8dab78f347a060aaf087763913f46dc4109542d6c57ce4308a2fcdb85d
ad436781cc513db4b51ae89559c5421ce0227273e70b1ba5195016ec1fad8433
ae95aebebe48759f966fb35dfc606baafecc3a1ad12bedad254e6194ef11fd98
aec60bc104db041b1512185839f18f52986df7e569e5445f740dd60f763fbca8
aefe7785628510514a9b8239ce581219565b33e13a778208e8740c4b0b617d80
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277
b109aa01643584538e73bdace10ac6836329a4b020210a8ef41df7ac4b203889
b49f9c1fdfb1d6199509d3d33ceb8c3355f15f8f12f9e97be20c8616d375be7f
b541d631712bc34f7472aabf9cdeaf0fcb2257fd2436ffced1530f5d4f5a0383
b6d5c9dcdbf8b72ed7671ad83c337d8d36d45808f241f7f3636c49a3ea746cd3
b761119f6ee51a94c54a22c19e4ccf071c507d927872afab4b5db02d916ba21b
b769324e0921f9f649611113e65f528ebae5e140da8a7e63c5d6ea7bc7a33bc0
b89736430f0c3089ec96f72dcb85cb4ba00bb868724f4d976b05fb5e00b1a6f0
c0a96907ffc21c092c27dfc837b862b80fd42ce93a68b362d83eaac1f54758c7
c193fa47a8ff355952cd825a6d96074f55614a4cc46e4b7046f12a7cf497bee8
c4b4f8a477e1f3c92ec1644a9e2ffa760b13a3858ca131d9c79eed889649951b
cc971927254c785de9f2ebfd5447c658406cac08ed66ffd6daceabde3cf3f89b
cd33d0c53a9b2d35a4377f74c892f6edd0b7fd5889631b92601cc1a757f4c2e8
cecb3134e5b3ba52c57ae04e147f702d2a88ebffb11f7322c9c5044fe47a8efd
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda
cf7c208207a951cf789be1dcfb9fc4fa45462d89e40afe5783ed37d77de89cb3
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7
d31b51de2a05eeb3dbe7b0d51de3df006817e2f08f984f90c884486f2ccd9521
d4c24b3912f66537e8b9531aaf4f1e3a4f5b07c0e2c1df021f875f680d47085f
d787d4ee6b3b73aae9ea1ce8aeabb759a3038a2ec9e0fae901a958fa5edbd679
d7b2453833645964e9bb9b2b2e4dd82eaa51bf6f9b7aa9c857e8b17211886a54
da69dd7761d9d27f4f06e2672b6ae1f61730b37ed0fe85a1802652f8d54750e9
daaf47e176780239d864e64b1729d088b9e9a005e19b1bd39fda65dee2e26a6f
dbeae36aa0b1cfa4f2c3e334f599ca42baabde1c4a27d7e1735a0311f77a8d9e
ddaca1d4b1a403b6659b90b027a3a08e5aefd730f6def3fa0057b731654ffa4c
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
dfe93d7d93d8451fcf82e24fe974e2c56c034f550b7e341684d5d72719cc46ed
e1feaafecf95d6dfa9fd5dc4ade49fcb29c6a697c713e423940b83e00ae3ad35
e30f848c353b8ab801c18d2109527cb32a27f145262dccb3cd4db9f309cc53bb
e313c730dcdeb89c9c26e893f332a82cf764d61fc564a9b60dbb081bc6ba9c0a
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
e6969b69570c743952ab51b9fba22410be503db91b0566753d6da10894e76dad
ebc49e883a573dd0f1ee42a9c60d8a01420005131962dc533bad78f10a91f4d8
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
f1b9c2cc911f7349063d0e15e4c2bc26a854dd72bdf2af86d17c677e53e94ae8
f2a2e03cfa6b1581e0118a530802959d83e5985aeea14a78e3e31afd15ddd32c
f42f55dabbb15175140e8f22510310cbeefe9d766975ce806a9d6f8d9444e66f
f44cacee437e1a4a3951d3021b0d27b1c8c6d8aaf747e6e03014c4b03dc4c4db
f8c80a13afa0faa19786701dfa52172e99065bf1e625988e6038b431d7fcb466
f909a31bfd7a13b9dd53e98b5652f13f4782fdfd1653dc4befade7386c087371
fb45b13e87546ec1238f394cee24cdb9b4dc9cbd9cbd50a33ddaa22c536b4624
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b
fd222137f245c06ddb4c4d44db41f12138dad6cf8ef5d4d4a5e500f38f0c8c62